{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "f5abe5c0",
   "metadata": {},
   "source": [
    "## Importing Required Libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "978d791a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import json\n",
    "import re\n",
    "from typing import List, Dict, Any, Tuple\n",
    "import faiss\n",
    "from sentence_transformers import SentenceTransformer\n",
    "from openai import OpenAI\n",
    "import time\n",
    "from sklearn.metrics import accuracy_score, precision_score, recall_score, f1_score\n",
    "import seaborn as sns\n",
    "from dotenv import load_dotenv\n",
    "import openai\n",
    "import os\n",
    "from langchain_community.utilities import GoogleSerperAPIWrapper\n",
    "\n",
    "\n",
    "\n",
    "# ✅ Load environment variables\n",
    "load_dotenv()\n",
    "openai_api_key = os.getenv(\"OPEN_AI_KEY\")\n",
    "SERPER_API_KEY = os.getenv(\"SERPER_API_KEY\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9ae7a502",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "51fa1b89",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting langchain_community\n",
      "  Downloading langchain_community-0.4-py3-none-any.whl.metadata (3.0 kB)\n",
      "Requirement already satisfied: langchain-core<2.0.0,>=1.0.0 in ./.venv/lib/python3.12/site-packages (from langchain_community) (1.0.0)\n",
      "Collecting langchain-classic<2.0.0,>=1.0.0 (from langchain_community)\n",
      "  Downloading langchain_classic-1.0.0-py3-none-any.whl.metadata (3.9 kB)\n",
      "Collecting SQLAlchemy<3.0.0,>=1.4.0 (from langchain_community)\n",
      "  Downloading sqlalchemy-2.0.44-cp312-cp312-macosx_11_0_arm64.whl.metadata (9.5 kB)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.32.5 in ./.venv/lib/python3.12/site-packages (from langchain_community) (2.32.5)\n",
      "Requirement already satisfied: PyYAML<7.0.0,>=5.3.0 in ./.venv/lib/python3.12/site-packages (from langchain_community) (6.0.3)\n",
      "Requirement already satisfied: aiohttp<4.0.0,>=3.8.3 in ./.venv/lib/python3.12/site-packages (from langchain_community) (3.12.15)\n",
      "Requirement already satisfied: tenacity!=8.4.0,<10.0.0,>=8.1.0 in ./.venv/lib/python3.12/site-packages (from langchain_community) (9.1.2)\n",
      "Collecting dataclasses-json<0.7.0,>=0.6.7 (from langchain_community)\n",
      "  Using cached dataclasses_json-0.6.7-py3-none-any.whl.metadata (25 kB)\n",
      "Collecting pydantic-settings<3.0.0,>=2.10.1 (from langchain_community)\n",
      "  Downloading pydantic_settings-2.11.0-py3-none-any.whl.metadata (3.4 kB)\n",
      "Requirement already satisfied: langsmith<1.0.0,>=0.1.125 in ./.venv/lib/python3.12/site-packages (from langchain_community) (0.4.37)\n",
      "Collecting httpx-sse<1.0.0,>=0.4.0 (from langchain_community)\n",
      "  Downloading httpx_sse-0.4.3-py3-none-any.whl.metadata (9.7 kB)\n",
      "Requirement already satisfied: numpy>=1.26.2 in ./.venv/lib/python3.12/site-packages (from langchain_community) (2.3.3)\n",
      "Requirement already satisfied: aiohappyeyeballs>=2.5.0 in ./.venv/lib/python3.12/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (2.6.1)\n",
      "Requirement already satisfied: aiosignal>=1.4.0 in ./.venv/lib/python3.12/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.4.0)\n",
      "Requirement already satisfied: attrs>=17.3.0 in ./.venv/lib/python3.12/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (25.3.0)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in ./.venv/lib/python3.12/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.7.0)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in ./.venv/lib/python3.12/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (6.6.4)\n",
      "Requirement already satisfied: propcache>=0.2.0 in ./.venv/lib/python3.12/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (0.4.0)\n",
      "Requirement already satisfied: yarl<2.0,>=1.17.0 in ./.venv/lib/python3.12/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.20.1)\n",
      "Collecting marshmallow<4.0.0,>=3.18.0 (from dataclasses-json<0.7.0,>=0.6.7->langchain_community)\n",
      "  Using cached marshmallow-3.26.1-py3-none-any.whl.metadata (7.3 kB)\n",
      "Collecting typing-inspect<1,>=0.4.0 (from dataclasses-json<0.7.0,>=0.6.7->langchain_community)\n",
      "  Using cached typing_inspect-0.9.0-py3-none-any.whl.metadata (1.5 kB)\n",
      "Collecting langchain-text-splitters<2.0.0,>=1.0.0 (from langchain-classic<2.0.0,>=1.0.0->langchain_community)\n",
      "  Downloading langchain_text_splitters-1.0.0-py3-none-any.whl.metadata (2.6 kB)\n",
      "Requirement already satisfied: pydantic<3.0.0,>=2.7.4 in ./.venv/lib/python3.12/site-packages (from langchain-classic<2.0.0,>=1.0.0->langchain_community) (2.11.10)\n",
      "Requirement already satisfied: jsonpatch<2.0.0,>=1.33.0 in ./.venv/lib/python3.12/site-packages (from langchain-core<2.0.0,>=1.0.0->langchain_community) (1.33)\n",
      "Requirement already satisfied: packaging<26.0.0,>=23.2.0 in ./.venv/lib/python3.12/site-packages (from langchain-core<2.0.0,>=1.0.0->langchain_community) (25.0)\n",
      "Requirement already satisfied: typing-extensions<5.0.0,>=4.7.0 in ./.venv/lib/python3.12/site-packages (from langchain-core<2.0.0,>=1.0.0->langchain_community) (4.15.0)\n",
      "Requirement already satisfied: jsonpointer>=1.9 in ./.venv/lib/python3.12/site-packages (from jsonpatch<2.0.0,>=1.33.0->langchain-core<2.0.0,>=1.0.0->langchain_community) (3.0.0)\n",
      "Requirement already satisfied: httpx<1,>=0.23.0 in ./.venv/lib/python3.12/site-packages (from langsmith<1.0.0,>=0.1.125->langchain_community) (0.28.1)\n",
      "Requirement already satisfied: orjson>=3.9.14 in ./.venv/lib/python3.12/site-packages (from langsmith<1.0.0,>=0.1.125->langchain_community) (3.11.3)\n",
      "Requirement already satisfied: requests-toolbelt>=1.0.0 in ./.venv/lib/python3.12/site-packages (from langsmith<1.0.0,>=0.1.125->langchain_community) (1.0.0)\n",
      "Requirement already satisfied: zstandard>=0.23.0 in ./.venv/lib/python3.12/site-packages (from langsmith<1.0.0,>=0.1.125->langchain_community) (0.25.0)\n",
      "Requirement already satisfied: anyio in ./.venv/lib/python3.12/site-packages (from httpx<1,>=0.23.0->langsmith<1.0.0,>=0.1.125->langchain_community) (4.11.0)\n",
      "Requirement already satisfied: certifi in ./.venv/lib/python3.12/site-packages (from httpx<1,>=0.23.0->langsmith<1.0.0,>=0.1.125->langchain_community) (2025.10.5)\n",
      "Requirement already satisfied: httpcore==1.* in ./.venv/lib/python3.12/site-packages (from httpx<1,>=0.23.0->langsmith<1.0.0,>=0.1.125->langchain_community) (1.0.9)\n",
      "Requirement already satisfied: idna in ./.venv/lib/python3.12/site-packages (from httpx<1,>=0.23.0->langsmith<1.0.0,>=0.1.125->langchain_community) (3.10)\n",
      "Requirement already satisfied: h11>=0.16 in ./.venv/lib/python3.12/site-packages (from httpcore==1.*->httpx<1,>=0.23.0->langsmith<1.0.0,>=0.1.125->langchain_community) (0.16.0)\n",
      "Requirement already satisfied: annotated-types>=0.6.0 in ./.venv/lib/python3.12/site-packages (from pydantic<3.0.0,>=2.7.4->langchain-classic<2.0.0,>=1.0.0->langchain_community) (0.7.0)\n",
      "Requirement already satisfied: pydantic-core==2.33.2 in ./.venv/lib/python3.12/site-packages (from pydantic<3.0.0,>=2.7.4->langchain-classic<2.0.0,>=1.0.0->langchain_community) (2.33.2)\n",
      "Requirement already satisfied: typing-inspection>=0.4.0 in ./.venv/lib/python3.12/site-packages (from pydantic<3.0.0,>=2.7.4->langchain-classic<2.0.0,>=1.0.0->langchain_community) (0.4.2)\n",
      "Requirement already satisfied: python-dotenv>=0.21.0 in ./.venv/lib/python3.12/site-packages (from pydantic-settings<3.0.0,>=2.10.1->langchain_community) (1.1.1)\n",
      "Requirement already satisfied: charset_normalizer<4,>=2 in ./.venv/lib/python3.12/site-packages (from requests<3.0.0,>=2.32.5->langchain_community) (3.4.3)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in ./.venv/lib/python3.12/site-packages (from requests<3.0.0,>=2.32.5->langchain_community) (2.3.0)\n",
      "Collecting mypy-extensions>=0.3.0 (from typing-inspect<1,>=0.4.0->dataclasses-json<0.7.0,>=0.6.7->langchain_community)\n",
      "  Downloading mypy_extensions-1.1.0-py3-none-any.whl.metadata (1.1 kB)\n",
      "Requirement already satisfied: sniffio>=1.1 in ./.venv/lib/python3.12/site-packages (from anyio->httpx<1,>=0.23.0->langsmith<1.0.0,>=0.1.125->langchain_community) (1.3.1)\n",
      "Downloading langchain_community-0.4-py3-none-any.whl (2.5 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.5/2.5 MB\u001b[0m \u001b[31m5.7 MB/s\u001b[0m  \u001b[33m0:00:00\u001b[0m eta \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hUsing cached dataclasses_json-0.6.7-py3-none-any.whl (28 kB)\n",
      "Downloading httpx_sse-0.4.3-py3-none-any.whl (9.0 kB)\n",
      "Downloading langchain_classic-1.0.0-py3-none-any.whl (1.0 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.0/1.0 MB\u001b[0m \u001b[31m7.5 MB/s\u001b[0m  \u001b[33m0:00:00\u001b[0m\n",
      "\u001b[?25hDownloading langchain_text_splitters-1.0.0-py3-none-any.whl (33 kB)\n",
      "Using cached marshmallow-3.26.1-py3-none-any.whl (50 kB)\n",
      "Downloading pydantic_settings-2.11.0-py3-none-any.whl (48 kB)\n",
      "Downloading sqlalchemy-2.0.44-cp312-cp312-macosx_11_0_arm64.whl (2.1 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.1/2.1 MB\u001b[0m \u001b[31m6.6 MB/s\u001b[0m  \u001b[33m0:00:00\u001b[0m eta \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hUsing cached typing_inspect-0.9.0-py3-none-any.whl (8.8 kB)\n",
      "Downloading mypy_extensions-1.1.0-py3-none-any.whl (5.0 kB)\n",
      "Installing collected packages: SQLAlchemy, mypy-extensions, marshmallow, httpx-sse, typing-inspect, pydantic-settings, dataclasses-json, langchain-text-splitters, langchain-classic, langchain_community\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m10/10\u001b[0m [langchain_community]ngchain_community]\n",
      "\u001b[1A\u001b[2KSuccessfully installed SQLAlchemy-2.0.44 dataclasses-json-0.6.7 httpx-sse-0.4.3 langchain-classic-1.0.0 langchain-text-splitters-1.0.0 langchain_community-0.4 marshmallow-3.26.1 mypy-extensions-1.1.0 pydantic-settings-2.11.0 typing-inspect-0.9.0\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "# pip install langchain_community"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6c920cd3",
   "metadata": {},
   "source": [
    "## Downloading the Dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "8dec05a4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(500, 3)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>qtype</th>\n",
       "      <th>Question</th>\n",
       "      <th>Answer</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>frequency</td>\n",
       "      <td>How many people are affected by X-linked chond...</td>\n",
       "      <td>The prevalence of X-linked chondrodysplasia pu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>treatment</td>\n",
       "      <td>What are the treatments for Kawasaki disease ?</td>\n",
       "      <td>These resources address the diagnosis or manag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>genetic changes</td>\n",
       "      <td>What are the genetic changes related to Ellis-...</td>\n",
       "      <td>Ellis-van Creveld syndrome can be caused by mu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>symptoms</td>\n",
       "      <td>What are the symptoms of Renal dysplasia-limb ...</td>\n",
       "      <td>What are the signs and symptoms of Renal dyspl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>information</td>\n",
       "      <td>What is (are) Fraser syndrome ?</td>\n",
       "      <td>Fraser syndrome is a rare disorder that affect...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             qtype                                           Question  \\\n",
       "0        frequency  How many people are affected by X-linked chond...   \n",
       "1        treatment     What are the treatments for Kawasaki disease ?   \n",
       "2  genetic changes  What are the genetic changes related to Ellis-...   \n",
       "3         symptoms  What are the symptoms of Renal dysplasia-limb ...   \n",
       "4      information                    What is (are) Fraser syndrome ?   \n",
       "\n",
       "                                              Answer  \n",
       "0  The prevalence of X-linked chondrodysplasia pu...  \n",
       "1  These resources address the diagnosis or manag...  \n",
       "2  Ellis-van Creveld syndrome can be caused by mu...  \n",
       "3  What are the signs and symptoms of Renal dyspl...  \n",
       "4  Fraser syndrome is a rare disorder that affect...  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## Data 1: reading the Comprehensive Medical Q&A Dataset\n",
    "df_qa = pd.read_csv(\"medical_q_n_a.csv\")\n",
    "## Data has 16407 rows, hence we will sample 500 rows for experimentation\n",
    "df_qa = df_qa.sample(500, random_state=0).reset_index(drop=True)\n",
    "print(df_qa.shape)\n",
    "df_qa.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "4ef57312",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>qtype</th>\n",
       "      <th>Question</th>\n",
       "      <th>Answer</th>\n",
       "      <th>combined_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>frequency</td>\n",
       "      <td>How many people are affected by X-linked chond...</td>\n",
       "      <td>The prevalence of X-linked chondrodysplasia pu...</td>\n",
       "      <td>Question: How many people are affected by X-li...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>treatment</td>\n",
       "      <td>What are the treatments for Kawasaki disease ?</td>\n",
       "      <td>These resources address the diagnosis or manag...</td>\n",
       "      <td>Question: What are the treatments for Kawasaki...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>genetic changes</td>\n",
       "      <td>What are the genetic changes related to Ellis-...</td>\n",
       "      <td>Ellis-van Creveld syndrome can be caused by mu...</td>\n",
       "      <td>Question: What are the genetic changes related...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>symptoms</td>\n",
       "      <td>What are the symptoms of Renal dysplasia-limb ...</td>\n",
       "      <td>What are the signs and symptoms of Renal dyspl...</td>\n",
       "      <td>Question: What are the symptoms of Renal dyspl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>information</td>\n",
       "      <td>What is (are) Fraser syndrome ?</td>\n",
       "      <td>Fraser syndrome is a rare disorder that affect...</td>\n",
       "      <td>Question: What is (are) Fraser syndrome ?. Ans...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             qtype                                           Question  \\\n",
       "0        frequency  How many people are affected by X-linked chond...   \n",
       "1        treatment     What are the treatments for Kawasaki disease ?   \n",
       "2  genetic changes  What are the genetic changes related to Ellis-...   \n",
       "3         symptoms  What are the symptoms of Renal dysplasia-limb ...   \n",
       "4      information                    What is (are) Fraser syndrome ?   \n",
       "\n",
       "                                              Answer  \\\n",
       "0  The prevalence of X-linked chondrodysplasia pu...   \n",
       "1  These resources address the diagnosis or manag...   \n",
       "2  Ellis-van Creveld syndrome can be caused by mu...   \n",
       "3  What are the signs and symptoms of Renal dyspl...   \n",
       "4  Fraser syndrome is a rare disorder that affect...   \n",
       "\n",
       "                                       combined_text  \n",
       "0  Question: How many people are affected by X-li...  \n",
       "1  Question: What are the treatments for Kawasaki...  \n",
       "2  Question: What are the genetic changes related...  \n",
       "3  Question: What are the symptoms of Renal dyspl...  \n",
       "4  Question: What is (are) Fraser syndrome ?. Ans...  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Preparing the Dataframe for Vector DB by combining the Text\n",
    "df_qa['combined_text'] = (\n",
    "    \"Question: \" + df_qa['Question'].astype(str) + \". \" +\n",
    "    \"Answer: \" + df_qa['Answer'].astype(str) + \". \" +\n",
    "    \"Type: \" + df_qa['qtype'].astype(str) + \". \"\n",
    ")\n",
    "\n",
    "df_qa.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "7561cc40",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(2694, 16)\n",
      "(500, 16)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Device_Name</th>\n",
       "      <th>Model_Number</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>Manual_Version</th>\n",
       "      <th>Publication_Date</th>\n",
       "      <th>Device_Class</th>\n",
       "      <th>Regulatory_Approval_ID</th>\n",
       "      <th>Patient_Population</th>\n",
       "      <th>Indications_for_Use</th>\n",
       "      <th>Contraindications</th>\n",
       "      <th>Sterilization_Method</th>\n",
       "      <th>Number_of_Warnings</th>\n",
       "      <th>Number_of_Cautions</th>\n",
       "      <th>Device_Lifetime_Years</th>\n",
       "      <th>Device_Weight_kg</th>\n",
       "      <th>Max_Operating_Temperature_C</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Electrosurgical Unit</td>\n",
       "      <td>Model 1606</td>\n",
       "      <td>Zimmer Biomet</td>\n",
       "      <td>2023-04-Z</td>\n",
       "      <td>2018-04-28</td>\n",
       "      <td>Class IIb</td>\n",
       "      <td>MDR-847127</td>\n",
       "      <td>All</td>\n",
       "      <td>Used for thermal therapy guidance in oncology ...</td>\n",
       "      <td>Contraindicated in presence of radio frequenci...</td>\n",
       "      <td>Hydrogen Peroxide Plasma</td>\n",
       "      <td>10</td>\n",
       "      <td>15</td>\n",
       "      <td>15.0</td>\n",
       "      <td>6.71</td>\n",
       "      <td>27.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Dialysis Machine</td>\n",
       "      <td>X-6538</td>\n",
       "      <td>3M Healthcare</td>\n",
       "      <td>v2.8</td>\n",
       "      <td>2018-04-03</td>\n",
       "      <td>Class I</td>\n",
       "      <td>MDR-416480</td>\n",
       "      <td>Adult (&gt;65)</td>\n",
       "      <td>Used for post-operative chemotherapy managemen...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gamma Irradiation</td>\n",
       "      <td>8</td>\n",
       "      <td>11</td>\n",
       "      <td>11.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>17.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Ventilator</td>\n",
       "      <td>SON230</td>\n",
       "      <td>Sonova</td>\n",
       "      <td>Version 13</td>\n",
       "      <td>2022-02-24</td>\n",
       "      <td>Class III</td>\n",
       "      <td>BLA670706</td>\n",
       "      <td>Adult (&gt;65)</td>\n",
       "      <td>Indicated for real-time temperature assessment...</td>\n",
       "      <td>Do not use during general anesthesia administr...</td>\n",
       "      <td>Pre-Sterilized</td>\n",
       "      <td>18</td>\n",
       "      <td>28</td>\n",
       "      <td>11.0</td>\n",
       "      <td>149.42</td>\n",
       "      <td>25.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Dialysis Machine</td>\n",
       "      <td>Max787</td>\n",
       "      <td>Boston Scientific</td>\n",
       "      <td>v4.7</td>\n",
       "      <td>2016-05-08</td>\n",
       "      <td>Class II</td>\n",
       "      <td>BLA131698</td>\n",
       "      <td>Neonatal</td>\n",
       "      <td>Intended for sterilization guidance during min...</td>\n",
       "      <td>Not recommended during pregnancy, lactation, o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10</td>\n",
       "      <td>15</td>\n",
       "      <td>15.0</td>\n",
       "      <td>20.96</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Electrosurgical Unit</td>\n",
       "      <td>Plus691</td>\n",
       "      <td>Abbott</td>\n",
       "      <td>2020-03-Q</td>\n",
       "      <td>2015-01-30</td>\n",
       "      <td>Class III</td>\n",
       "      <td>H127393</td>\n",
       "      <td>Pediatric</td>\n",
       "      <td>Intended for life support evaluation in rehabi...</td>\n",
       "      <td>Contraindicated in patients with severe diabet...</td>\n",
       "      <td>Single-Use Sterile</td>\n",
       "      <td>13</td>\n",
       "      <td>17</td>\n",
       "      <td>8.0</td>\n",
       "      <td>7.75</td>\n",
       "      <td>31.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            Device_Name Model_Number       Manufacturer Manual_Version  \\\n",
       "0  Electrosurgical Unit   Model 1606      Zimmer Biomet      2023-04-Z   \n",
       "1      Dialysis Machine       X-6538      3M Healthcare           v2.8   \n",
       "2            Ventilator       SON230             Sonova     Version 13   \n",
       "3      Dialysis Machine       Max787  Boston Scientific           v4.7   \n",
       "4  Electrosurgical Unit      Plus691             Abbott      2020-03-Q   \n",
       "\n",
       "  Publication_Date Device_Class Regulatory_Approval_ID Patient_Population  \\\n",
       "0       2018-04-28    Class IIb             MDR-847127                All   \n",
       "1       2018-04-03      Class I             MDR-416480        Adult (>65)   \n",
       "2       2022-02-24    Class III              BLA670706        Adult (>65)   \n",
       "3       2016-05-08     Class II              BLA131698           Neonatal   \n",
       "4       2015-01-30    Class III                H127393          Pediatric   \n",
       "\n",
       "                                 Indications_for_Use  \\\n",
       "0  Used for thermal therapy guidance in oncology ...   \n",
       "1  Used for post-operative chemotherapy managemen...   \n",
       "2  Indicated for real-time temperature assessment...   \n",
       "3  Intended for sterilization guidance during min...   \n",
       "4  Intended for life support evaluation in rehabi...   \n",
       "\n",
       "                                   Contraindications  \\\n",
       "0  Contraindicated in presence of radio frequenci...   \n",
       "1                                                NaN   \n",
       "2  Do not use during general anesthesia administr...   \n",
       "3  Not recommended during pregnancy, lactation, o...   \n",
       "4  Contraindicated in patients with severe diabet...   \n",
       "\n",
       "       Sterilization_Method  Number_of_Warnings  Number_of_Cautions  \\\n",
       "0  Hydrogen Peroxide Plasma                  10                  15   \n",
       "1         Gamma Irradiation                   8                  11   \n",
       "2            Pre-Sterilized                  18                  28   \n",
       "3                       NaN                  10                  15   \n",
       "4        Single-Use Sterile                  13                  17   \n",
       "\n",
       "   Device_Lifetime_Years  Device_Weight_kg  Max_Operating_Temperature_C  \n",
       "0                   15.0              6.71                         27.0  \n",
       "1                   11.0               NaN                         17.0  \n",
       "2                   11.0            149.42                         25.0  \n",
       "3                   15.0             20.96                         20.0  \n",
       "4                    8.0              7.75                         31.0  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## Data 2: reading the Medical Device Manuals Dataset\n",
    "df_medical_device = pd.read_csv(\"medical_device_manuals_dataset.csv\")\n",
    "print(df_medical_device.shape)\n",
    "## Data has 2694 rows, hence we will sample 500 rows for experimentation\n",
    "df_medical_device = df_medical_device.sample(500, random_state=0).reset_index(drop=True)\n",
    "print(df_medical_device.shape)\n",
    "df_medical_device.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "1b80cec8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Device_Name</th>\n",
       "      <th>Model_Number</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>Manual_Version</th>\n",
       "      <th>Publication_Date</th>\n",
       "      <th>Device_Class</th>\n",
       "      <th>Regulatory_Approval_ID</th>\n",
       "      <th>Patient_Population</th>\n",
       "      <th>Indications_for_Use</th>\n",
       "      <th>Contraindications</th>\n",
       "      <th>Sterilization_Method</th>\n",
       "      <th>Number_of_Warnings</th>\n",
       "      <th>Number_of_Cautions</th>\n",
       "      <th>Device_Lifetime_Years</th>\n",
       "      <th>Device_Weight_kg</th>\n",
       "      <th>Max_Operating_Temperature_C</th>\n",
       "      <th>combined_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Electrosurgical Unit</td>\n",
       "      <td>Model 1606</td>\n",
       "      <td>Zimmer Biomet</td>\n",
       "      <td>2023-04-Z</td>\n",
       "      <td>2018-04-28</td>\n",
       "      <td>Class IIb</td>\n",
       "      <td>MDR-847127</td>\n",
       "      <td>All</td>\n",
       "      <td>Used for thermal therapy guidance in oncology ...</td>\n",
       "      <td>Contraindicated in presence of radio frequenci...</td>\n",
       "      <td>Hydrogen Peroxide Plasma</td>\n",
       "      <td>10</td>\n",
       "      <td>15</td>\n",
       "      <td>15.0</td>\n",
       "      <td>6.71</td>\n",
       "      <td>27.0</td>\n",
       "      <td>Device Name: Electrosurgical Unit. Model: Mode...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Dialysis Machine</td>\n",
       "      <td>X-6538</td>\n",
       "      <td>3M Healthcare</td>\n",
       "      <td>v2.8</td>\n",
       "      <td>2018-04-03</td>\n",
       "      <td>Class I</td>\n",
       "      <td>MDR-416480</td>\n",
       "      <td>Adult (&gt;65)</td>\n",
       "      <td>Used for post-operative chemotherapy managemen...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gamma Irradiation</td>\n",
       "      <td>8</td>\n",
       "      <td>11</td>\n",
       "      <td>11.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>17.0</td>\n",
       "      <td>Device Name: Dialysis Machine. Model: X-6538. ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Ventilator</td>\n",
       "      <td>SON230</td>\n",
       "      <td>Sonova</td>\n",
       "      <td>Version 13</td>\n",
       "      <td>2022-02-24</td>\n",
       "      <td>Class III</td>\n",
       "      <td>BLA670706</td>\n",
       "      <td>Adult (&gt;65)</td>\n",
       "      <td>Indicated for real-time temperature assessment...</td>\n",
       "      <td>Do not use during general anesthesia administr...</td>\n",
       "      <td>Pre-Sterilized</td>\n",
       "      <td>18</td>\n",
       "      <td>28</td>\n",
       "      <td>11.0</td>\n",
       "      <td>149.42</td>\n",
       "      <td>25.0</td>\n",
       "      <td>Device Name: Ventilator. Model: SON230. Manufa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Dialysis Machine</td>\n",
       "      <td>Max787</td>\n",
       "      <td>Boston Scientific</td>\n",
       "      <td>v4.7</td>\n",
       "      <td>2016-05-08</td>\n",
       "      <td>Class II</td>\n",
       "      <td>BLA131698</td>\n",
       "      <td>Neonatal</td>\n",
       "      <td>Intended for sterilization guidance during min...</td>\n",
       "      <td>Not recommended during pregnancy, lactation, o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10</td>\n",
       "      <td>15</td>\n",
       "      <td>15.0</td>\n",
       "      <td>20.96</td>\n",
       "      <td>20.0</td>\n",
       "      <td>Device Name: Dialysis Machine. Model: Max787. ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Electrosurgical Unit</td>\n",
       "      <td>Plus691</td>\n",
       "      <td>Abbott</td>\n",
       "      <td>2020-03-Q</td>\n",
       "      <td>2015-01-30</td>\n",
       "      <td>Class III</td>\n",
       "      <td>H127393</td>\n",
       "      <td>Pediatric</td>\n",
       "      <td>Intended for life support evaluation in rehabi...</td>\n",
       "      <td>Contraindicated in patients with severe diabet...</td>\n",
       "      <td>Single-Use Sterile</td>\n",
       "      <td>13</td>\n",
       "      <td>17</td>\n",
       "      <td>8.0</td>\n",
       "      <td>7.75</td>\n",
       "      <td>31.0</td>\n",
       "      <td>Device Name: Electrosurgical Unit. Model: Plus...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            Device_Name Model_Number       Manufacturer Manual_Version  \\\n",
       "0  Electrosurgical Unit   Model 1606      Zimmer Biomet      2023-04-Z   \n",
       "1      Dialysis Machine       X-6538      3M Healthcare           v2.8   \n",
       "2            Ventilator       SON230             Sonova     Version 13   \n",
       "3      Dialysis Machine       Max787  Boston Scientific           v4.7   \n",
       "4  Electrosurgical Unit      Plus691             Abbott      2020-03-Q   \n",
       "\n",
       "  Publication_Date Device_Class Regulatory_Approval_ID Patient_Population  \\\n",
       "0       2018-04-28    Class IIb             MDR-847127                All   \n",
       "1       2018-04-03      Class I             MDR-416480        Adult (>65)   \n",
       "2       2022-02-24    Class III              BLA670706        Adult (>65)   \n",
       "3       2016-05-08     Class II              BLA131698           Neonatal   \n",
       "4       2015-01-30    Class III                H127393          Pediatric   \n",
       "\n",
       "                                 Indications_for_Use  \\\n",
       "0  Used for thermal therapy guidance in oncology ...   \n",
       "1  Used for post-operative chemotherapy managemen...   \n",
       "2  Indicated for real-time temperature assessment...   \n",
       "3  Intended for sterilization guidance during min...   \n",
       "4  Intended for life support evaluation in rehabi...   \n",
       "\n",
       "                                   Contraindications  \\\n",
       "0  Contraindicated in presence of radio frequenci...   \n",
       "1                                                NaN   \n",
       "2  Do not use during general anesthesia administr...   \n",
       "3  Not recommended during pregnancy, lactation, o...   \n",
       "4  Contraindicated in patients with severe diabet...   \n",
       "\n",
       "       Sterilization_Method  Number_of_Warnings  Number_of_Cautions  \\\n",
       "0  Hydrogen Peroxide Plasma                  10                  15   \n",
       "1         Gamma Irradiation                   8                  11   \n",
       "2            Pre-Sterilized                  18                  28   \n",
       "3                       NaN                  10                  15   \n",
       "4        Single-Use Sterile                  13                  17   \n",
       "\n",
       "   Device_Lifetime_Years  Device_Weight_kg  Max_Operating_Temperature_C  \\\n",
       "0                   15.0              6.71                         27.0   \n",
       "1                   11.0               NaN                         17.0   \n",
       "2                   11.0            149.42                         25.0   \n",
       "3                   15.0             20.96                         20.0   \n",
       "4                    8.0              7.75                         31.0   \n",
       "\n",
       "                                       combined_text  \n",
       "0  Device Name: Electrosurgical Unit. Model: Mode...  \n",
       "1  Device Name: Dialysis Machine. Model: X-6538. ...  \n",
       "2  Device Name: Ventilator. Model: SON230. Manufa...  \n",
       "3  Device Name: Dialysis Machine. Model: Max787. ...  \n",
       "4  Device Name: Electrosurgical Unit. Model: Plus...  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Preparing the Dataframe for Vector DB by combining the Text\n",
    "df_medical_device['combined_text'] = (\n",
    "    \"Device Name: \" + df_medical_device['Device_Name'].astype(str) + \". \" +\n",
    "    \"Model: \" + df_medical_device['Model_Number'].astype(str) + \". \" +\n",
    "    \"Manufacturer: \" + df_medical_device['Manufacturer'].astype(str) + \". \" +\n",
    "    \"Indications: \" + df_medical_device['Indications_for_Use'].astype(str) + \". \" +\n",
    "    \"Contraindications: \" + df_medical_device['Contraindications'].fillna('None').astype(str)\n",
    ")\n",
    "df_medical_device.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b61f3d77",
   "metadata": {},
   "source": [
    "## Setting up Vector Store (ChromaDB)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b475b122",
   "metadata": {},
   "source": [
    "### Creating the Chroma DB client "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "9763ed34",
   "metadata": {},
   "outputs": [],
   "source": [
    "import chromadb\n",
    "# Setting up the Chromadb\n",
    "client = chromadb.PersistentClient(path=\"./chroma_db\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f0b2532a",
   "metadata": {},
   "source": [
    "### Creating the Collections"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "eab4296f",
   "metadata": {},
   "source": [
    "We will create two collections, one for device manual dataset and one for Q&D Dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "ba81a8d9",
   "metadata": {},
   "outputs": [],
   "source": [
    "client.delete_collection(name=\"medical_q_n_a\")\n",
    "collection1 = client.get_or_create_collection(name=\"medical_q_n_a\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "e0e8fbe3",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Add data to collection\n",
    "# here the chroma db will use default embeddings (sentence transformers)\n",
    "collection1.add(\n",
    "    documents=df_qa['combined_text'].tolist(),\n",
    "    metadatas=df_qa.to_dict(orient=\"records\"),\n",
    "    ids=df_qa.index.astype(str).tolist(),\n",
    ")\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "3e3abe9f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ids': [['1', '393', '60', '102', '174']], 'embeddings': None, 'documents': [[\"Question: What are the treatments for Kawasaki disease ?. Answer: These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care. Type: treatment. \", 'Question: What are the treatments for Krabbe Disease ?. Answer: There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.. Type: treatment. ', 'Question: What are the treatments for Ehlers-Danlos syndrome, progeroid type ?. Answer: How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.. Type: treatment. ', 'Question: What are the treatments for Von Hippel-Lindau Disease (VHL) ?. Answer: Treatment for VHL varies according to the location and size of the tumor. In general, the objective of treatment is to treat the tumors before they grow to a size large enough to cause permanent problems by putting pressure on the brain or spinal cord. this pressure can block the flow of cerebrospinal fluid in the nervous system, impair vision, or create deafness. Treatment of most cases of VHL usually involves surgery to remove the tumors before they become harmful. Certain tumors can be treated with focused high-dose irradiation. Individuals with VHL need careful monitoring by a physician and/or medical team familiar with the disorder.. Type: treatment. ', 'Question: What are the treatments for Omsk Hemorrhagic Fever (OHF) ?. Answer: There is no specific treatment for OHF, but supportive therapy is important. Supportive therapy includes the maintenance of hydration and the usual precautions for patients with bleeding disorders. \\n                \\nThough rare, OHF can cause hearing loss, hair loss, and behavioral or psychological difficulties associated with neurological conditions and long term supportive case may be needed.. Type: treatment. ']], 'uris': None, 'included': ['metadatas', 'documents', 'distances'], 'data': None, 'metadatas': [[{'combined_text': \"Question: What are the treatments for Kawasaki disease ?. Answer: These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care. Type: treatment. \", 'qtype': 'treatment', 'Question': 'What are the treatments for Kawasaki disease ?', 'Answer': \"These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care\"}, {'qtype': 'treatment', 'Answer': 'There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.', 'combined_text': 'Question: What are the treatments for Krabbe Disease ?. Answer: There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.. Type: treatment. ', 'Question': 'What are the treatments for Krabbe Disease ?'}, {'Question': 'What are the treatments for Ehlers-Danlos syndrome, progeroid type ?', 'qtype': 'treatment', 'Answer': 'How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.', 'combined_text': 'Question: What are the treatments for Ehlers-Danlos syndrome, progeroid type ?. Answer: How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.. Type: treatment. '}, {'qtype': 'treatment', 'combined_text': 'Question: What are the treatments for Von Hippel-Lindau Disease (VHL) ?. Answer: Treatment for VHL varies according to the location and size of the tumor. In general, the objective of treatment is to treat the tumors before they grow to a size large enough to cause permanent problems by putting pressure on the brain or spinal cord. this pressure can block the flow of cerebrospinal fluid in the nervous system, impair vision, or create deafness. Treatment of most cases of VHL usually involves surgery to remove the tumors before they become harmful. Certain tumors can be treated with focused high-dose irradiation. Individuals with VHL need careful monitoring by a physician and/or medical team familiar with the disorder.. Type: treatment. ', 'Answer': 'Treatment for VHL varies according to the location and size of the tumor. In general, the objective of treatment is to treat the tumors before they grow to a size large enough to cause permanent problems by putting pressure on the brain or spinal cord. this pressure can block the flow of cerebrospinal fluid in the nervous system, impair vision, or create deafness. Treatment of most cases of VHL usually involves surgery to remove the tumors before they become harmful. Certain tumors can be treated with focused high-dose irradiation. Individuals with VHL need careful monitoring by a physician and/or medical team familiar with the disorder.', 'Question': 'What are the treatments for Von Hippel-Lindau Disease (VHL) ?'}, {'combined_text': 'Question: What are the treatments for Omsk Hemorrhagic Fever (OHF) ?. Answer: There is no specific treatment for OHF, but supportive therapy is important. Supportive therapy includes the maintenance of hydration and the usual precautions for patients with bleeding disorders. \\n                \\nThough rare, OHF can cause hearing loss, hair loss, and behavioral or psychological difficulties associated with neurological conditions and long term supportive case may be needed.. Type: treatment. ', 'qtype': 'treatment', 'Question': 'What are the treatments for Omsk Hemorrhagic Fever (OHF) ?', 'Answer': 'There is no specific treatment for OHF, but supportive therapy is important. Supportive therapy includes the maintenance of hydration and the usual precautions for patients with bleeding disorders. \\n                \\nThough rare, OHF can cause hearing loss, hair loss, and behavioral or psychological difficulties associated with neurological conditions and long term supportive case may be needed.'}]], 'distances': [[0.4760013818740845, 0.9692587852478027, 1.0237324237823486, 1.0586740970611572, 1.1096043586730957]]}\n"
     ]
    }
   ],
   "source": [
    "# quick check\n",
    "query = \"What are the treatments for Kawasaki disease ?\"\n",
    "\n",
    "results = collection1.query(query_texts=[query],\n",
    "    n_results=5\n",
    ")\n",
    "print(results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "e84d1a0e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'ids': [['1', '393', '60']],\n",
       " 'embeddings': None,\n",
       " 'documents': [[\"Question: What are the treatments for Kawasaki disease ?. Answer: These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care. Type: treatment. \",\n",
       "   'Question: What are the treatments for Krabbe Disease ?. Answer: There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.. Type: treatment. ',\n",
       "   'Question: What are the treatments for Ehlers-Danlos syndrome, progeroid type ?. Answer: How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.. Type: treatment. ']],\n",
       " 'uris': None,\n",
       " 'included': ['metadatas', 'documents', 'distances'],\n",
       " 'data': None,\n",
       " 'metadatas': [[{'qtype': 'treatment',\n",
       "    'Question': 'What are the treatments for Kawasaki disease ?',\n",
       "    'Answer': \"These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care\",\n",
       "    'combined_text': \"Question: What are the treatments for Kawasaki disease ?. Answer: These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care. Type: treatment. \"},\n",
       "   {'qtype': 'treatment',\n",
       "    'combined_text': 'Question: What are the treatments for Krabbe Disease ?. Answer: There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.. Type: treatment. ',\n",
       "    'Answer': 'There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.',\n",
       "    'Question': 'What are the treatments for Krabbe Disease ?'},\n",
       "   {'qtype': 'treatment',\n",
       "    'combined_text': 'Question: What are the treatments for Ehlers-Danlos syndrome, progeroid type ?. Answer: How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.. Type: treatment. ',\n",
       "    'Answer': 'How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.',\n",
       "    'Question': 'What are the treatments for Ehlers-Danlos syndrome, progeroid type ?'}]],\n",
       " 'distances': [[0.4760013818740845, 0.9692587852478027, 1.0237324237823486]]}"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "collection1.query(query_texts=[query], n_results=3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 165,
   "id": "6a5a54ff",
   "metadata": {},
   "outputs": [],
   "source": [
    "client.delete_collection(name=\"medical_device_manual\")\n",
    "collection2 = client.get_or_create_collection(name=\"medical_device_manual\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 166,
   "id": "a14a0525",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Add data to collection\n",
    "# here the chroma db will use default embeddings (sentence transformers)\n",
    "collection2.add(\n",
    "    documents=df_medical_device['combined_text'].tolist(),\n",
    "    metadatas=df_medical_device.to_dict(orient=\"records\"),\n",
    "    ids=df_medical_device.index.astype(str).tolist(),\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "id": "067d32ea",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ids': [['218', '149', '235', '67', '174']], 'embeddings': None, 'documents': [['Device Name: Pacemaker. Model: JOH663. Manufacturer: Johnson & Johnson. Indications: Designed for catheterization support in neonatal intensive care environments.. Contraindications: Avoid use in patients with cardiac devices or cochlear implants. Not suitable for chemical exposure areas.', 'Device Name: Infusion Pump. Model: Model 7800. Manufacturer: Intuitive Surgical. Indications: Designed for joint replacement support in neonatal intensive care environments.. Contraindications: Not recommended for use in geriatric patients or those with hepatic dysfunction.', 'Device Name: Anesthesia Machine. Model: STR623. Manufacturer: Stryker. Indications: Designed for tissue biopsy support in neonatal intensive care environments.. Contraindications: Do not use in combination with sedatives or oxygen therapy modalities.', 'Device Name: Orthopedic Implant. Model: PHI214. Manufacturer: Philips Healthcare. Indications: Designed for defibrillation support in neonatal intensive care environments.. Contraindications: Do not use if patient has known allergy to latex proteins or hypersensitivity to cleaning solvents.', 'Device Name: ECG Machine. Model: Pro723. Manufacturer: Siemens Healthineers. Indications: Designed for catheterization support in neonatal intensive care environments.. Contraindications: Contraindicated in presence of blood thinners or during ultrasound therapy.']], 'uris': None, 'included': ['metadatas', 'documents', 'distances'], 'data': None, 'metadatas': [[{'Regulatory_Approval_ID': 'H148086', 'Contraindications': 'Avoid use in patients with cardiac devices or cochlear implants. Not suitable for chemical exposure areas.', 'Device_Class': 'Class II', 'Number_of_Cautions': 10, 'Device_Name': 'Pacemaker', 'Model_Number': 'JOH663', 'Publication_Date': '2023-09-27', 'Device_Weight_kg': 0.06, 'Sterilization_Method': 'Not Applicable', 'Patient_Population': 'Adult (18-65)', 'Number_of_Warnings': 10, 'Max_Operating_Temperature_C': 39.0, 'Indications_for_Use': 'Designed for catheterization support in neonatal intensive care environments.', 'combined_text': 'Device Name: Pacemaker. Model: JOH663. Manufacturer: Johnson & Johnson. Indications: Designed for catheterization support in neonatal intensive care environments.. Contraindications: Avoid use in patients with cardiac devices or cochlear implants. Not suitable for chemical exposure areas.', 'Manufacturer': 'Johnson & Johnson', 'Manual_Version': '2021-01-A'}, {'Device_Lifetime_Years': 12.0, 'Model_Number': 'Model 7800', 'Sterilization_Method': 'Dry Heat', 'Regulatory_Approval_ID': 'PMDA-473669', 'Device_Name': 'Infusion Pump', 'Number_of_Warnings': 8, 'Max_Operating_Temperature_C': 31.0, 'Device_Weight_kg': 2.83, 'Manual_Version': '2020-05-S', 'Number_of_Cautions': 18, 'combined_text': 'Device Name: Infusion Pump. Model: Model 7800. Manufacturer: Intuitive Surgical. Indications: Designed for joint replacement support in neonatal intensive care environments.. Contraindications: Not recommended for use in geriatric patients or those with hepatic dysfunction.', 'Patient_Population': 'Adult and Pediatric', 'Manufacturer': 'Intuitive Surgical', 'Contraindications': 'Not recommended for use in geriatric patients or those with hepatic dysfunction.', 'Indications_for_Use': 'Designed for joint replacement support in neonatal intensive care environments.', 'Device_Class': 'Class IIb', 'Publication_Date': '2024-01-21'}, {'Number_of_Warnings': 16, 'Device_Name': 'Anesthesia Machine', 'Manufacturer': 'Stryker', 'Contraindications': 'Do not use in combination with sedatives or oxygen therapy modalities.', 'Sterilization_Method': 'Not Applicable', 'Device_Weight_kg': 51.65, 'Regulatory_Approval_ID': 'BLA811783', 'Device_Lifetime_Years': 14.0, 'Max_Operating_Temperature_C': 31.0, 'Number_of_Cautions': 17, 'Manual_Version': 'Rev. 5.6', 'Indications_for_Use': 'Designed for tissue biopsy support in neonatal intensive care environments.', 'Model_Number': 'STR623', 'Publication_Date': '2017-09-04', 'Device_Class': 'Class I', 'Patient_Population': 'Geriatric', 'combined_text': 'Device Name: Anesthesia Machine. Model: STR623. Manufacturer: Stryker. Indications: Designed for tissue biopsy support in neonatal intensive care environments.. Contraindications: Do not use in combination with sedatives or oxygen therapy modalities.'}, {'Publication_Date': '2024-05-16', 'Manufacturer': 'Philips Healthcare', 'combined_text': 'Device Name: Orthopedic Implant. Model: PHI214. Manufacturer: Philips Healthcare. Indications: Designed for defibrillation support in neonatal intensive care environments.. Contraindications: Do not use if patient has known allergy to latex proteins or hypersensitivity to cleaning solvents.', 'Device_Name': 'Orthopedic Implant', 'Number_of_Warnings': 9, 'Patient_Population': 'Infant (0-2)', 'Device_Weight_kg': 0.16, 'Indications_for_Use': 'Designed for defibrillation support in neonatal intensive care environments.', 'Number_of_Cautions': 11, 'Device_Class': 'Class I', 'Model_Number': 'PHI214', 'Device_Lifetime_Years': 25.0, 'Sterilization_Method': 'UV Sterilization', 'Manual_Version': '2025-08-F', 'Regulatory_Approval_ID': 'PMA834539', 'Contraindications': 'Do not use if patient has known allergy to latex proteins or hypersensitivity to cleaning solvents.'}, {'Model_Number': 'Pro723', 'Device_Weight_kg': 10.45, 'Patient_Population': 'Infant (0-2)', 'Contraindications': 'Contraindicated in presence of blood thinners or during ultrasound therapy.', 'Number_of_Cautions': 7, 'Manual_Version': 'Rev. 7.6', 'Number_of_Warnings': 4, 'Indications_for_Use': 'Designed for catheterization support in neonatal intensive care environments.', 'Device_Name': 'ECG Machine', 'Device_Class': 'Class III', 'Device_Lifetime_Years': 13.0, 'Publication_Date': '2021-12-23', 'Manufacturer': 'Siemens Healthineers', 'combined_text': 'Device Name: ECG Machine. Model: Pro723. Manufacturer: Siemens Healthineers. Indications: Designed for catheterization support in neonatal intensive care environments.. Contraindications: Contraindicated in presence of blood thinners or during ultrasound therapy.', 'Regulatory_Approval_ID': 'Q127708', 'Sterilization_Method': 'Chemical Sterilization', 'Max_Operating_Temperature_C': 31.0}]], 'distances': [[1.0503746271133423, 1.0830397605895996, 1.0891238451004028, 1.0902631282806396, 1.11448073387146]]}\n"
     ]
    }
   ],
   "source": [
    "# quick check\n",
    "query = \"Which devices are suitable for neonatal patients?\"\n",
    "\n",
    "results = collection2.query(query_texts=[query],\n",
    "    n_results=5\n",
    ")\n",
    "print(results)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3a36eae5",
   "metadata": {},
   "source": [
    "## Setting up WebSearch API"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cab150c2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"Different types of COVID-19 vaccines: How they work · mRNA vaccine · mRNA vaccine · Messenger RNA (mRNA) vaccine · Viral vector vaccine · Viral vector vaccine ... First introduced in December 2020, the original COVID mRNA vaccines from both Pfizer and Moderna protected against the original SARS-CoV-2 virus ... Currently, there are two types of COVID-19 vaccines for use in the United States: mRNA, and protein subunit vaccines. None of these vaccines can ... On this page, you will find infographics to explain how different types of vaccines work, including the Pfizer/BioNTech vaccine, the Moderna vaccine and the ... Types of COVID-19 vaccines. Two types of COVID-19 vaccines are recommended for use in the United States: mRNA vaccines. Moderna COVID-19 Vaccine ... List of COVID-19 vaccine authorizations · Contents · Overview maps · Oxford–AstraZeneca · Pfizer–BioNTech · Janssen · Moderna · Sinopharm BIBP · Sputnik V. WHO recommends a simplified single-dose regime for primary immunization for most COVID-19 vaccines which would improve acceptance and uptake and provide ... Find information and answers to your questions about the COVID-19 vaccine, including scheduling, kid's shots, boosters, additional doses, records and more. The California Department of Public Health is dedicated to optimizing the health and well-being of Californians. Find out how the COVID-19 vaccines work, how many doses are needed, possible side effects and who shouldn't get the vaccine.\""
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "search = GoogleSerperAPIWrapper()\n",
    "\n",
    "# testing the google search API\n",
    "search.run(query=\"What are the various vaccines of COVID-19\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "71fa76e7",
   "metadata": {},
   "source": [
    "## Setting up the Open AI Client"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "id": "ab013bdc",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_core.tools import tool"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "id": "6b96ab7f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Relativity says physics laws work for observers, with no preferred frame, and nothing travels faster than light. Time and space bend with motion and gravity, equating mass and energy fundamentally.\n"
     ]
    }
   ],
   "source": [
    "from openai import OpenAI\n",
    "\n",
    "\n",
    "def get_llm_response(prompt: str) -> str:\n",
    "    \"\"\"Function to get response from LLM\"\"\"\n",
    "    from openai import OpenAI\n",
    "    client_llm = OpenAI(api_key=openai_api_key)\n",
    "    response = client_llm.chat.completions.create(\n",
    "        model=\"gpt-5-nano\",\n",
    "        messages=[{\"role\": \"user\", \"content\": prompt}]\n",
    "    )\n",
    "    return response.choices[0].message.content\n",
    "\n",
    "## testing the LLM response\n",
    "prompt = \"Explain the theory of relativity in simple terms in 30 words\"\n",
    "response = get_llm_response(prompt)\n",
    "\n",
    "print(response)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "17532fcc",
   "metadata": {},
   "source": [
    "## Part A: Traditional RAG"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 170,
   "id": "abffacdc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from typing import Literal\n",
    "from langgraph.graph import StateGraph,MessagesState, START, END\n",
    "from openai import OpenAI\n",
    "from typing_extensions import TypedDict\n",
    "from typing import List\n",
    "\n",
    "# === Define workflow node functions ===\n",
    "def retrieve_context(state):\n",
    "    \"\"\"Retrieve top documents from ChromaDB based on query.\"\"\"\n",
    "    print(\"---RETRIEVING CONTEXT---\")\n",
    "    query = state[\"query\"] # last user message\n",
    "\n",
    "    results = collection1.query(query_texts=[query], n_results=3)\n",
    "    context = \"\\n\".join(results[\"documents\"][0])\n",
    "\n",
    "    #state[\"query\"] = query\n",
    "    state[\"context\"] = context\n",
    "    print(context)\n",
    "    # Save context in the state for later nodes\n",
    "    return state\n",
    "\n",
    "def build_prompt(state):\n",
    "    \"\"\"Construct the RAG-style prompt.\"\"\"\n",
    "    print(\"---BUILDING PROMPT---\")\n",
    "    query = state[\"query\"]\n",
    "    context = state[\"context\"]\n",
    "\n",
    "    prompt = f\"\"\"\n",
    "            Answer the following question using the context below.\n",
    "\n",
    "            Context:\n",
    "            {context}\n",
    "\n",
    "            Question: {query}\n",
    "\n",
    "            please limit your answer in 50 words.\n",
    "            \"\"\"\n",
    "    \n",
    "    state[\"prompt\"] = prompt\n",
    "    print(prompt)\n",
    "    return state\n",
    "\n",
    "def call_llm(state):\n",
    "    \"\"\"Call your existing LLM function.\"\"\"\n",
    "    print(\"---CALLING LLM---\")\n",
    "    prompt = state[\"prompt\"]\n",
    "    answer = get_llm_response(prompt)\n",
    "    state[\"response\"] = answer\n",
    "    return state\n",
    "\n",
    "# === Build the workflow ===\n",
    "\n",
    "## Define the state structure\n",
    "class GraphState(TypedDict):\n",
    "    query : str\n",
    "    prompt : str\n",
    "    context : List[str]\n",
    "    response : str\n",
    "\n",
    "    \n",
    "workflow = StateGraph(GraphState)\n",
    "\n",
    "# Add nodes\n",
    "workflow.add_node(\"Retriever\", retrieve_context)\n",
    "workflow.add_node(\"PromptBuilder\", build_prompt)\n",
    "workflow.add_node(\"LLM\", call_llm)\n",
    "\n",
    "# Define edges\n",
    "workflow.add_edge(START, \"Retriever\")\n",
    "workflow.add_edge(\"Retriever\", \"PromptBuilder\")\n",
    "workflow.add_edge(\"PromptBuilder\", \"LLM\")\n",
    "workflow.add_edge(\"LLM\", END)\n",
    "\n",
    "# Compile agent\n",
    "rag_agent = workflow.compile()\n",
    "\n",
    "# === Run it ===\n",
    "from IPython.display import Image, display\n",
    "display(Image(rag_agent.get_graph().draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 171,
   "id": "9610c378",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "---RETRIEVING CONTEXT---\n",
      "Question: What are the treatments for Kawasaki disease ?. Answer: These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care. Type: treatment. \n",
      "Question: What are the treatments for Krabbe Disease ?. Answer: There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.. Type: treatment. \n",
      "Question: What are the treatments for Ehlers-Danlos syndrome, progeroid type ?. Answer: How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.. Type: treatment. \n",
      "'Finished running: Retriever:'\n",
      "---BUILDING PROMPT---\n",
      "\n",
      "            Answer the following question using the context below.\n",
      "\n",
      "            Context:\n",
      "            Question: What are the treatments for Kawasaki disease ?. Answer: These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care. Type: treatment. \n",
      "Question: What are the treatments for Krabbe Disease ?. Answer: There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.. Type: treatment. \n",
      "Question: What are the treatments for Ehlers-Danlos syndrome, progeroid type ?. Answer: How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.. Type: treatment. \n",
      "\n",
      "            Question: What are the treatments for Kawasaki disease ?\n",
      "\n",
      "            please limit your answer in 50 words.\n",
      "            \n",
      "'Finished running: PromptBuilder:'\n",
      "---CALLING LLM---\n",
      "'Finished running: LLM:'\n",
      "('Treatment centers on reducing inflammation and preventing heart problems. '\n",
      " 'Most children receive a single infusion of intravenous immunoglobulin (IVIG) '\n",
      " 'plus high‑dose aspirin during the first 10 days, followed by low-dose '\n",
      " 'aspirin for several weeks or months. Some cases require repeat IVIG, '\n",
      " 'steroids, or other therapies.')\n"
     ]
    }
   ],
   "source": [
    "input_state = {\"query\": \"What are the treatments for Kawasaki disease ?\"}\n",
    "\n",
    "from pprint import pprint\n",
    "for step in rag_agent.stream(input_state):\n",
    "    for key, value in step.items():\n",
    "        pprint(f\"Finished running: {key}:\")\n",
    "pprint(value[\"response\"])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5a191fa7",
   "metadata": {},
   "source": [
    "## Part B: Agentic RAG"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "adeb0af1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAeYAAAKsCAIAAAC22okPAAAQAElEQVR4nOzdB2DT1hYG4Cs7m0AYgbD33hvKhhBm2XtT9oYCZRYoqy2bsqEUCgUKj713mWGPsPcmbAgJ2Ymtd2wF4yROYiu2I9n/V16eLMmybF0dXZ17JTnwPM8AAEAOHBgAAMgEQjYAgGwgZAMAyAZCNgCAbCBkAwDIBkI2AIBsIGSDSMc2v373PCo8VMUYRy8dHLjoaE2HUU7BeHXMPEoHTvV1JP3h1ZphhYLj+ZjOpZySYzQYMz+nUDK1KqbXKc1Gf9Vq/us0+hhO91I7JmaBOvQWtTpup1WDI5VKTqWK172VYwrOwMzaL6JQRauZIUolc3Rh+UqkLu+TgcnB3pUvvnxWR4TF/Zr0cwujdL8YbYE4P4Zm29FsscdyHGegr7BucfrvVRvoUxzzcfHmj78+8T9OfzvGmS3WS72Fc5oSZ2gFDJUoYSSnVw5ZQuuvNz9voBDSEhJ7F3F0Vri4cRXrp81eIDVLGId+2WCqyDDV6slPKIa6uTtERfCcQhOPtdFWM1V/P/+2M2jCb8yuwmn3n5i9kdMMxJRBXluy9XYt/fJJLzV7jl5pjb/vxR9DrzW7UPx4Ymi/MrwELcMhXniLA8+rVOGhvIMj12tqPiZhl499PL83wNmNubg6RkXGnUo/NSf86LofIV4Y5emoxuL97Lq5eOHwrR2p2XRcrNm0R+dvcyQtZuY4G0X/pX4opE/jEioeiX6sbk7DW19T8AzFya/LjHPESqgIJfShOo4O6shoFvpFlSW3U8tBORN8I0I2mCQ4IOzvaf4V6qcrWkkelUqr2fP3o5APfK+p+Zkkndn34dqxz61G5HR1dWIgYRtmPMyUw7lF/xwGpyoYgCnWzfAvWyc94nV833fPlzq9w+rJj5j0vHoa5nfsc+ef8yNeS1/H0fk/vIzYv8bf4FSEbDDBmd3v6TSwRLX0DAxp1CN3WBAf/CmMScyx/71NmxHBWjbylkzz4p7hUoSQDSZ49STc2c34XKQ9Ujpx1898YRITGhidLjNCtmwUKpc6OtLwJPQYARNEhPBREQjZiYmO5MNCJPcTRYZTe5eSgUy4e7iqow1PQsgGAJANhGwAANlAyAYwM2SOIJkSKUII2QDmpOCES4sAxEvkYhmEbDCBQskpUIdMlJrnVWomNZyCYcPJScIbCyEbTIQ9X4Z4NVPjMmcZSXhjIWSDCdQ8bnAAYHmoZYN5qBlCduKUlDvCXgXJhFo2gHWoVHxCF0EAJB9CNoBdQBuEbUDIBhNw2PNlCwktGdHcTTuBLYaQDSbglByHTseJUnBMqUB4hGThee2TFQzB/gemoKLEo56dGDXPVGpb+ImGDOs1esxgZhWTfhk1YmR/ZgH3H9yt7V3+5Kn/4k/aum2jt09FZgrLrafxELLBBGpN996UrEJOnjJm3/6dzHQtWvm8eu3PQJQnTx617/g9Myv9TVmjhrePTyNmXUWLFO/SuZdJb9FfT9FFMZmQGAE5uXfvdoUK3zETvXnz+vPnAAZi3bt/m5mb/qb0rlOfWV2RIsXpn0lv0V9PcUXRSLjHCJgHp7DSBevnzvtu2rT27r1b6dN7Fi9eqk+vwRkyeNIZLk2aNXvq0mXzdu88HhwcvHnLugsXzz59+ihDes8qVWr2+KG/i4sL057AKpVKL68sGzet7d6t799rltPITp2bVa1ac9qUOcyiOEmeunLi241X/71s7T8raYB+/wH9f2zTutOnTx+XLJ1789a18PBwCltdO/fKkSMX06YaNvy7+sdhY+n3b9687eCBI6l6vmv3litXL7558yp3rryNGjVv1rS1sCimtylp/uDgL3NmL6WRoaGhc+f/6ud36cuXIHpLw4bNmjdrw7Q1/R692i1ZvGbDhtWnfY9nzJipdq16fXoPpg3NRKG1pW9x9PAFGm7esi6Vk5cvn2/d9m/atOm+q1x90MCRv/4+wdf3BH21zh171KvXmGnLlbCecdafhg8c3L1r99YnTx7myZO/Tu16rVp2EJ59rF8U581ZXrp0OWPWLZEzWSRGwDRWSItQ/nHsuKFlylT4e9WWIYNHPXp0f8bMX2j8gX2+9PenkROEnWTbdgoQf7dr2+XX6fP79h16/MThNWtXCEtwdHR8/OQh/Zs+dS7FiN+mz6eR69fttHi8FlpoldJrfuTFb7gfuvdr366rl1fmY0cvUbxWqVQ/jujrd+3yj8PGrVq5KV3a9AMGdvN/9ZLmdHJyCg0N2bVry9gxU1o0a0tjFi+Zc/Hi2aFDRv/+2wKK138smEEHYxZvU+obM27Iq1cvp06Z87+N+ygRQW+5c/cW025T+jtn7jRv7waHDpwdP3ba/zavO3b8MDMHWvjGTWty5sx9cP+ZXj0H7j+w68fhfbzrNDh88FztWj6z5kz9EhzrSUNx1v/I0QMzZk4uWKDwhnW76O1btm5YtGSObsm6opgvf0FjVyjhvlmoZYMJeLU1Lli/ecOPKsudO/VQKBQUKQoXKkolPv5sbdt0rlnDO1euPDHvunntwsUzffsMYZo+UhxV65Yt+UeodFsTH82rVJJrfhRqfGZx44bf8+dPqaZZtkwFetm/3zDfMye2bt1AB1f6FKp3t2/fTZhEJkz4jYJ4lsxZabhM6fIHDuyibVS5UtWEFk4BnZZPR4I8efLRy04dfzh/wZeOxL//+ocwQ80adWvVrEsDpUqVzZol2/37d+p6N2DmUCB/4aZNWtFArZo+s+dMK1asJAVrekl1eTrJeP7sCY1J6L379u0oWbLMsKFjaDhduvQ/dOs3c/YUqpvTsMiiyCdYOULIBskpXqI07fljxw8rX67Sd9/VyJ4tB+3t8Wej+svFS2d/nzHp4aP70dGaKw5pD9FNzZUzj/XjtZRxZjpBunHTj355XVCmkFS6VLlr16/oZihcqNi3uXl+27aNFHZfvHgmjMiSJVsiC6fEAm01IV4LChYocvS/A99eFiyiG3Z3Tx0cbLbHbFIVWxhIlSoV/c2dO2YdXF3d6C9laRJ6o1qtphxR1y69dWPoBJFGXr9xlaoUTFxRxD1GQEboBJPOo0+ePLriz4VLls4rV7Yi5Rkpox1nNppKtRtKiVQo/x1Vxlf+tVi/Bd/J2ZnBV9q8iHkq2hQlo6KihGSuDuV/dcOUHhEGKGyNGTc0Kiqyd69BpUuXT+2eevDQnokv/OPHDy4urvpj3NzcwsJCdS8VFrsZeZwTEeM/KDIykn6Qv1YtoX/64wMCPgkDIooih3uMgFlwnJWufqxUsQr9oyzq5cvnqUVo3Phh27bGylpSgmb3nq2tW3X8vnELYYwZK1zJQT+RFO9MzZutEYLagV1dXadPm6c/Uqkw0AZIbRJ3796aPWsJHXSFMbSNMnpmYgmjGm54eJj+mJDQEM8MGZmEUQ2ajiv1fBrX0NapdbJmyc7EwiMOwDw4hRmTogny87scERlBIdvTM2P9+t9nzpx12PA+b96+1t/bqV4TFhbm+XUM1XTOnD3JJECh4Gz7ov58+QrSL58pU+ZsWWNC0qvX/mk90sWfMzDwM/3VbbWnTx/Tvzy58yWy8EIFi1JO7MHDewXyFxLG3LlzM3eexN4iBfSbUPukLn1HhfP1a/9MmbyYWImUIPQYARPwVrmQhjKDv0wetXvPts+fA27fublt+0aK3Zm9sjg7O2fMmOnSpXNX/S7ReSslH6ll3//VSwoN1NpTonhpSjiGhITEX2AObZry+PHDtDRmYZo7+UnvqTTJlD17TkpZnD59nFLSVGWuWLHK7NlT3759Q7/8jp2b+/XvQu2K8d+VO1deBweHTf/7J+hLELVYLlw0q0L5ynTopUn6m1JohxDQkrNmzT537vS7925/+vSRUg0Ustu16cKShw4V9EG6f7duXWfJE2f9e/cc5Ot7nPJylAui5tMpU8cOH9mPqhFMLNSywTw016tbPma3bdOZgvWixbPnzvuVEqN1atefN3cF7fxM04Wgx+q/l124eObfDXsmjP918ZI53X9oTWemA/oPp2zphQtnWrSqu+bvrXEWSPXBBvWb0BuLFys1b+5yBiaqXKkaHREnTBrZrWuf7t36/DZ9/q7dW6dMG3v79o0cOXLVrduwZcv28d9FDQzjx01bs3ZFs+Z1smXLMX7s1I+fPkyYOLLbD63XrN6ivyl1b6GtPG3KnGXL5w8Y2I02fd68BaZOmV2iRGmWPPRBcVZso96HiqO//rSGK5atX79h9fIVCyixU6xoyWlT5zpbpjWFw1NGwHj//v4iNCS67cg8DBKwdsrDwhU9vNtJK/26ZOTDfKU9qjSRdFIYdFRRbN20h4Pm548/CbVsMAHlRfAIwSRJsfWRx+OEZAU9RsAsTO0x0qRpLYPjVSoVJaMTaspc988OD4+0zAIozzhu/DCDkyjz6OjoaHCVcuXOu2jBKmYc+loKtBBZ0djxw27e8DM4qVGj5v37DWMyxCUctBGywQQ8Z9rNV1es2MBMZ6F4TTQ5xwRWKSQkOFUqd4OTHJQm7CZqNa+SXvMjZ7vdWEYO/zkyynBDn5v2Khg5SqQXPUI2mELN8ZwJAUm4UllSJLhKVsDzzFbzIhkyeDJ7gpANJuCUnBSvE4GkaGrZ2HA2ASEbwPah+VFmNMdXPPsRko1XM/QKTZxEL1gH+TFcjBCywRS89jmikBgOxzRILnTyA7NQcMhlJ4HnpXgegly2zUDIBhNwDtQCiV7H8oNctsxw6JcN5qCK4lXRNnfTIwCp4dEvGwBA/hCyAQBkAyEbTODkyqKjkMtOjKMT5yy9R046ODHc+URGwiMjuQRiMzYjmCBdZqfICBWDhEVH8XmKuzKJcXVXfn4XzkAmnlz7olQanoSQDSao2z5zdKTa/2EgA0NO7fB3dGHZ8rkziSn2XepPryMYyMS9S58zZXcyOAkhG0zzXZN0xza+V6lQ147r8c1PT2+G9Zgsxec/lKvjmSmX87+/P2QgedsXP6HI3HJwToNT8VQaMNnrxyHbF7928+DSeblqL60x0B9JwXie4+IWLo4KHCfcVI7jvvYU1twXlIphrIVorvv4OqfuvbG6qvKMU2ifG673RqqA6PdApFVTq3ndNSTaD+S+rYmwGF74OL0V4IS9gouzwtoViLkppv66OChYWFhU0Ifo8DBVn1/zKBM6oZWAw+tfP/AL8cjo4JHeWR3vB9f+FHp3/eR03/jrj6z92t823NfZhJHxt5e2b3GsMqCd6+uHxP7lhcVqfu3YV49y2oKk97n69yUVxurerL9mMZMMvSvmszWTdMVDb4sqFJxa+yCPWCXu6wKo1DE+zs+i9/sIc/Jff71Yv62mOUGt1papmBXQfnc+Zh0cHFnw58jP7yNdXJRdJyR44EfIBpH+98fT4E/qsBC1wccCULnXXr4Rq3QpOE4ds/9o42nMTqu9BU68ObX3C+VjjdGbi9O+UfsRal0AjhPV6SN4FeO/nknq79GcsN9wMeVfu2K83kryutmY3jFGd72+hxfr5wAAEABJREFU/jwODpyjM58xh/P3PbMzybt19pPficCIUD48LP6m4fWPedrNIvw+MeFKmEf7M36LgMJ25DRbUa1/GFB8jUX6jzFSaAMsjdff+vqbQBfO9AkbLuYtfKwagrDFhUkKxqljF5ivaxvnSCSE21jFQ79s0DGXziGFI3P86KiguMtrawK6yPttQPt1vpXSr7/b119VqeRUKl73lWOK4NdC6+TMOblwOYq41m6VmSUMIRvkbdKkSRUqVPj+++8ZgB1AJz+Qt+joaOHh6wD2AGUd5A0hG+wKyjrIG0I22BWUdZC3qKgoR0dHBmAfELJB3lDLBruCsg7yplKpELLBfqCsg7xRLVvKV68AmBdCNsgbctlgVxCyQd6Qywa7grIO8oaQDXYFZR3kDSEb7ArKOsgbQjbYFZR1kDc0P4JdQcgGeUMtG+wKyjrIG0I22BWUdZA3hGywKyjrIG/IZYNdQcgGeUMtG+wKyjrImEqlUigUBh8+CWCTELJBxlDFBnuD4g4yhpAN9gbFHWQMbY9gbxCyQcZQywZ7g+IOMsbzfNasWRmA3UDIBhmjKvaLFy8YgN1AyAYZo5BNuREGYDcQskHGELLB3iBkg4whZIO9QcgGGUPIBnujYACyxXGcQqFQqVQMwD4gZIO8oaINzJ4gZIO8IWSDXUEuG+QNIRvsCkI2yBtCNtgVhGyQN4RssCsI2SBvCNlgVxCyQd4QssGuIGSDvCFkg11ByAZ5Q8gGu4KQDfKGkA12BSEb5A0hG+wKx/M8A5CbMmXKMO09RggNqNVqKsnVqlVbtGgRA7BduGAdZKl69erCPaGEqK1UKtOnT9+1a1cGYNMQskGWunXr5unpqT+mcOHCFStWZAA2DSEbZKlcuXIlS5bUvXRzc2vfvj0DsHUI2SBXPXr0yJQpkzCcN2/eGjVqMABbh5ANclW0aFGhEdLJyaljx44MwA6gxwhYxMntr8ODueh4j4uh9kK1WlPkOI7pF704LwVKBVOp4y2Bo7mZWjs+ODj4qt9VRwfHypUra+fnNB1HDJVoeheNTqiwKxS8Ws0lsjJKJUvn5VCxnicDSFEI2WBmO5a8ePU4QuHAHBSKyMi4pYtin/DYL/2wyCl4xnPxS6JCyalVcccqFBR8OV4dM54KsNDPT7NwB838Bku0dh4Dk4TV4BTfFijMHGdWR2emVtE/vpxPWgRuSEG4lAbM6eS2d2+eRzQdks3Dw5XZnKd3Ak9te5/KXVmsSjoGkBJQywaz2bva//WT8HYj8jGbtm7aw5ptMxStgKgNKQDNj2A2L+6EFa/uwWxd5rzO5/Z+YgApASEbzOPNizDKBheraPt53rwl0kSE4twUUgZy2WAe4V9Uavu4O5OHp5OdfFOQIIRsMA9N3ztmF3VPPlrJqxlAikDIBgCQDYRsMBOOY3bCbr4oSBBCNpiJ/fQWRdMjpByEbAAA2UDIBgCQDYRsMBOO2UmWl0cuG1IOQjaYCc/sJMvLIZcNKQchGwBANhCyAQBkAyEbwGQ8OvpBCkHIBjPhOPu5yITD5TSQQhCywUxMb368/+Bu336d9ce4u7vnzVugdauO1avVZgAQD0I2mIvIXMEP3fuVKFFaGH769PGx44cmTvrp998WVKpYhYk1ecqYChW+a9SwGQOwLbhfNqSw3LnzlildXvjXonnbBfNX0pitWzewZLh37zazGPu5mQpIEEI2SE7ePPlfv3mle7n2n5WdujSv37BKl24t58ydrtY+XP3O3Vu1vcvTX91snbs0X7J0Hg3QeHr7rNlTmzSrJUw6cHD3gEHdGzauRn+3bN2ge3hesxbeW7f+O/TH3vSWyMhIZhw8eg9SEEI2mAdnvqsfX7166ZkhozC8+u9lO3b+r3/fYVs2H+zZY8DxE4c3b1mf+NsP7POlvz+NnLB753EaOHL0wIyZkwsWKLxh3a5ePQdSyF60ZI4wp6Oj45592/PnLzRr5mIHBxOShLgAElIKQjaYB2+Oqx+/BH9ZuHj23Xu3fXwaCS//3bimS+de1arVSu2eulbNui2at1u3/q+oqCjjl7lv346SJcsMGzomXbr0ZctU+KFbvx07/hcQoHl4I8dxadJ4DB44sny5SgqFCfsCLoCElILmRzAPXnP4F1P5nPTLKP2XXl6ZB/T/UWg5fPHiGUXnIkWK66YWLFgkODjY3/8FMw5lUW7euta1S2/dmDJlKtDI6zeu1qzhTS8LFSzKAOQDIRvMg2NqcbVsXY+RkODgX6aMbtigWZvWnYRJnz59oL8uzi66mV1d3ehvWFiokY2AlKGmoP/XqiX0T3+8UMsmTk5OzFR21AEdJAchG1KY0GNEGO7Qvtv6Davq1m2YLWt2epkqlTv9DQsP080cGhpCf9On9/wU8DHOcqJVBp6h6+Li4ubmVs+ncQ1tnVona5bsTDQeTzmAFINcNpiLGWqelLamjPPs2VOFl/nyFVQqlbduXdPNcOfOTUpqZ8yYydnJmQnVbS3Klnz48N7gMmkhlBPX9SMsXqxUhvSemTJ5MQAZQsgGczFDzZPSFIMGjvS7dnn/gV30Mk3qND51G61bv+rMmZNBX4IOHdq7fcem1q07UVNhjhy5KHbv27+T5/no6OjfZ05KnTqNsBBnZ2eK6Zcunbvqd4km9e45yNf3OM1JKewbN/ymTB07fGQ/47v0AUgKEiNgHryZUrzVq9UuW6bCsuV/VK1ai0L2wAEjKEBPnT6Ogm/WrNk7dviBkidM2z9vwoTf/lgwo07dCp6eGfv2Gfrp00ddh+tOHXus/nvZhYtn/t2whxLlK5atX79h9fIVC8LDw4oVLTlt6lwK6wxAhjgeFwaAOTy/E7xrxetuvxRgtu7Di8i9K58Pmp+fAVgdatkApkFvEUhBCNkAplFzuM0IpBiEbDATzl4iGcfjNiOQYhCywUx4RDIAi0PIBjANjkuQghCyAUyDPDakIFxKA+bx/MVLZicUqGhDikHIhmS5dOlSeHi4SqXasCFZz5GRE7Wmol2rVq2VK1cyAOtCyAYxAgMD6W/Xrl3//PNPpdaY0aOYPdm9e3fevHlp4OzZs1OnTn38+DEDsDyEbDAWVaXpL9WmK1as+P695h5My5YtW758uaOjo3a6feV4U6dOXadOHRqoUKFCiRIlKHDT8MmTJ8+fP88ALAYhG5J2//79wYMHb926lYZLlixJ4Sl/fs3l2m5ubnpz2WmC18HBoXnz5p06ae7xnSlTpjVr1uzapbmn1d27dxmAuSFkg2GUoV63bt1ff/1Fwx8+fOjQoUPbtm1puHjx4pQGYWBI4cKFlyxZ0rBhQxo+duxY9erVX716xQDMByEbYqEKtVCbvn37NmU/6tWrR8NVtBgYR8gU9e/f/+DBg8KJSIsWLaZMmcIAkg0hGzT8/Pzo7+fPnydNmiSMKVu27I8//pgjRw4jl6BWMaWDXaSzo/lopXHXM1C8Tps2LQ2sX7++VKlSNEBHQYrd169fZwCi4FIauxYSEpIqVap27dq5u7tTDoSa1P79918mSu7i7mq1ponS5tMmb56EmVrVodjdrJnmAcSenp4Uu6n2TU0ClOz++PFj1apVGYDRUMu2U9RKRrmOgIAAGl6+fLmQs05mtHV1V5zY8pbZusfXv3hmNf0hv1ocx1Hs/umnn2iYKuCbNm2aP38+DT979owBGAEh245QeppyHXv27GHaVkRqH8ueXfPUWuHkPfk6/JTl5b3QwMAwZruObXoRHhzdZlhOlmyZM2desGDBgAEDaPjmzZvUVnnt2jUGkCg8lcbGhYeH79y5U6FQtGnT5ujRo9QyVqNGDWZJi0Y8TJvRIWfRVOm8XDl13Ow2H6//Nr3kudhdBL++FGbmDPUf5A31A+cS6GmoGy+8Rc0buE0sr62/8PHmj1mgOvqdf+SzO0GUsu85JR+zgNDQUMqTUOPB8OHDKUM1atQoylkxgNgQsm3TkydP7ty506hRoxMnTpw/f75Dhw7GNyQm34aZz4I+RqlUjFeZ9kaet8Y9t0V8CrWsOjjyaTM7thmSi1lYZGTkoUOHypcvT9XwmTNnVqtWDd11QAch26ZQi1bhwoX9/f2HDh3apUsXockL4hsxYkSTJk1q1arFpO2Q1uzZsz9//kzJEwrfDOwbQrYtiIiIcHZ2pgCdJUuWZcuWRUVFfb2IHBK0cuXKHj16UMqIyQGlTcaOHUsV8KVLl3748MHT05OBXULIlre//vpr7dq127Zty5AhA/ZkmyccjKmVsl+/fpMmTWrQoAEDO4OQLT90grxmzZrvv/++Zs2ap0+fLl26tLu7OwPTUUWbzksaN27M5Iaq2w8fPixatOjChQvfv38/ePDgjBkzMrADCNnyEB4evnfvXjc3t4YNG+7atYtitHAbOUgmyjYMHz5cvvEuOjr64MGD1FBZrly5VatW5cuXjw7kDGwXQrakvXz58tGjR7QTUrym02FqUbRmxw+Ql/Pnz2/atGnIkCG5c+f29fXFdZU2CSFbip4+fUp7HZ35jhgxonfv3pQDYWAxFOmCg4O9vb2ZDRkzZgx9r2PHjoWFhbm6ujKwFQjZEqJSqWhztGzZkuL1ggULKBni4uLCwPLouNi/f/+yZcsyG0I5EwcHh3fv3jVr1qxXr149e/ZkIH8I2ZKwfPnyLVu27Ny509nZ+c2bN9myZWNgXTZcG6W2yqtXr1aqVOnAgQMnT56k2E0pbwbyhJCdYm7evLlhw4bWrVtT5e7w4cPUfJQ+fXoGKeTt27fv378vXrw4s120sx86dCgqKopSbdQ6kipVKulfTARxKH/55RcG1kL1HdpVKDrkypXryJEjRYoUqVatGsdxVOtBwjFlubu7L1q0KDQ0tGDBgsxGUUnLnz+/8AXVavW///6rVCrz5s175cqVLFmyMJAD1LKtgfKJT548oTNT2knu379PZ6bCLfRAanx9fWkzUQqY2Qfa/SmOL168eM2aNQcPHkyXLh0DaUPItqCXL19SaL5x48aoUaOGDBkiPBIQpIzqnnQmZIetvtT0TQkT+uJ02kcFdfz48QwkCSHbIuj8ukuXLnTKOWvWrODgYFydKCNU5aQkVY8ePZhdooPWiRMnateu/ejRo7/++qtdu3bCI9BAIhCyzYmSoZSq3r9/f1hYGCWsc+fOzUCGVq9eTQ10uAScUiV0pkh5vMuXL3/+/NnGuq7LFEJ2ct28eXPLli2dO3emhp3du3dTJjRTpkwMwIa8fv163rx5efLk6d+/v3CDXwYpBCFbjOjo6EOHDlFoLl++/IoVK4RbC8nlNp5gjP/++48qmF27dmXwldBWuXPnzqlTp65du7Zo0aIMrA4h2wQfP3709/cvWbLk0qVLX716NXDgwMyZMzOwUdOmTaOGuHLlyjGIjYLG+/fvqcrSvXt3+jtlyhRcpms1CNlJo9JJac3z589PmDBh1KhRdevWZQCgdfToUTrX9PDwGD16NJ1rWvrJooBz+cR8+jK/e7gAABAASURBVPSJWsznz59Pw4UKFaJkCOK1XXn69Ck1JjNIGLVJUrymAR8fn1OnTjFt31aK4wwsA7VsA6il5eLFixs2bAgICKBkCLUrMrBXv/76Kx2tW7VqxcA4QUFBlFOKioqi/YjCd9asWdHMY0YI2TH8/Px2795NDeKenp4bN26sU6cOOn6A4O3bt1QqlEolAxNduHCBmnzosEd1cKH1kkHy2HXIVqvVdAaXI0eOwoULz5kzJ1++fE2bNkWNAOIICwt78uQJOkiIRr9enjx5qOpNFXBqDcITSpPDHkN2dHT0o0eP6GyXDv5UhkaOHIkyBIlbvXp1SEjIoEGDGCQD1ZCyZctGNSTKmdAhsH79+gxMZI8he9y4cVWqVMGjXsAkJ0+eLFGiBG6cZBbUVrR9+/YRI0ZkyJCBgSnsMWRv2rSpdu3aSFUDgOzYY962Xbt2iNdgquXLl79//56BmVy5cmXDhg0MTGSPIfvAgQNv3rxhAKagxMjHjx8ZmMnbt29v377NwET2cit3fTt37kyfPj2uNQeT9O3b18vLi4GZlC1bFre6FMEec9m7du0qXbp0zpw5GQCArOBSGgCj/PPPP9WrV0fF0Fwol3337t2OHTsyMIU95rKPHz/+7NkzBmCKc+fOoQnEjJDLFscec9kHDx6sXbt2rly5GIDRunbtijJjRshli2OPiZGjR49SIrtAgQIMAEBWkMsGMMrWrVuLFi1apEgRBuaAXLY49pjL9vX1pbLCAExBIQZNIGaEXLY49pjLppBNSUk8chRM0qpVK9w+zIyQyxbHHhMjZ86ccXNzK126NAMAkBXksgGMsm/fPi8vLzy911yQyxbHHnPZly9f9vPzYwCmuHXr1oMHDxiYCXLZ4thjLpsO7yqVCokRMEnDhg1dXFwYmAly2eLYY2Lk6tWrkZGRlSpVYgAAsmJHtey6desGBAToj1Gr1RkzZjx06BADSEDt2rWDgoKoqAiPmqW/NJw5c+b9+/czSAbkssWxo1x2/fr1uXgqV67MABJWq1YtOhNVKpUKLSoz9JfiOIPkQS5bHDsK2d27d49zw9VMmTJ16tSJASSMik327Nn1x1AVu0OHDgySh3LZ2PtEsKOQTTkQHx8f4fRWULJkyUKFCjGAhOXKlatatWr6YypWrJgjRw4GyePl5YWr/0Wwr05+lDjT1ZhSp06NgzwY44cffsiaNasw7OnpifSrWeDZj+LYV8j28PBo3Lgx5SJpuHjx4qVKlWIASaHzszp16gjnZ6VLl8Y9IM0CuWxxjOox8uROkDpKqT+GCq9a+zcOTtNpkBNm4L/+NUn8txhciP7I2MM8b2C9vqlets2lQi8DAwMb1ez06HoI+7qeotYqsbfSVC7eVP3lCDMk9X2TXju1ms9V1Ikwmfj4NizgrYpL+lc3LM4voity32bgNP8l+qYkFh6ndFFRr1Op4+2Ln4JDQupV6yoUmySXq799OW25jCORvSNO2UhyF0hwDK9ycnPIXsCNSQ/6ZYuTRL/sjbOefHpHexdTRcebZqi0Gi6F8ec0dg8SFmqovOstweD0JBdj5Ls0RwBxsSXJ72jSj5AwpQNFbebspmg/PIt7OlcmYef3v792KjAyXPvjq/UmJBy9RP/++ts3mb+0+DIg/iONqUcYVYIVDpoleeV1bNk/FwP5Syxkr5v5ODKEr94iU+Y8qRlI27Etr5/fCuk1PY+Lq5JJ0vN7X/b8+bbod2nL1cX98Kzq0c1P5/Z8ylHApXGP7Ewy0C9bnARD9t+THyudWfP+eRnIRGRk5L+/PR80Nz+TnrP73l0/GdRxrBTXzU5smvPQLbWy4095mDTs37/f19d32rRpDExhuPnx1tmA8BA14rW8UDo7fWan9b8/Y9Jz4/SXguVxrpaS2o3I//mtKjg4jEkD+mWLYzhk37kQ5OJujzf5k7tcxV2DAqKYxAR+DIuK4Mv7eDFIUQ7OzHfHRyYN6JctjuG4HBHOKR3s8SZ/cpfBy5WPZlIToG3BhhSndFCGBTGJQL9scQzH5ehINa/GXiZDvKbPH5MYBZPiWtmh6Eg+SjLnYOiXLQ6q0gCQAtAvWxyEbLACnLFJA2/6tW0W46XFwESGc9kKBafAXiZHvIKXYnxEVkQaOAkdPZHLFsdwyOZ5PMVXnjhqgsCWAxlALlscw4kRnufUiNmyJMWTIzVTcMiNSIDmviWcVDYEctniJJTL5qWzacEUHOMlt+EUmnthoAaQ8hRKOnhKZUMgly0OrpexMWommX1SD+K1JKhUvErNJAK5bHEM17JRwwYAi0IuW5yEctmoFwGABSGXLU5CtWxUs2VKkhuOV0gww26HlAqFUimVXChy2eIksP141LNlSko9b3U4SXYWtz8qtVolmWQ2ctniJNBjRME4E6tFP08c4et74tsCFIosWbKVKll2QP/hqVKlYskw6ZdRwcFf5sxeyqzl/oO7fft1Fobpi6RPn8HLK0uD+k2+b9yCJUOzFt6tWnbo2qUXsyC1JNv6TL7qTn8TCNzd3fPmLdC6Vcfq1WqzZNi6beOSpXOPHr7ArCs6Onrvvh2XLp27c/cmncUWKVy8UqWqVKiUShMeSbFz15b5f/xeu5bPxAm/MZlDLlucBHLZaiaiW3a2rNlHjPhZGA4NCbl46ezxE0devHz2x7w/k8y0tGjls3jR31mzZIs/qUYN76ioSGZ1P3TvV6JEadrTXr16ee/e7T8WzLh799aI4eNFZ43ate1StEgJBkYTNoEw/PTp42PHD02c9NPvvy2oVLFK4m+cPGVMhQrfNWrYLP6kokWKd+ls0aOmAS/9X4wbPyzg08c2bTrXq9eYCtXTp48WLZ594sSRaVPnGv/cziNH9+fMmdv3zIng4GA6hjE5Qy5bHHPeY8TF1bVM6fK6l1Wr1ixdujztPLdv3yhWrGQib3zz5vXnzwEJTfWuU5+lhNy58+p/nZo1644ZO4R2mLZtOjNROnbozsAU+puABlo0b/tDz7Zbt25IMmTTIZZCtsFJRYoUp3/MumbNnvLhw7sVy9Znz57z6zifqlVrDRzUfemyeUOHjDZmIS9fPr9589rCP/4aM27IiZNHGjdqzuQMuWxxErjHiJkyonnzaB4c9eq1v/Dy1q3ro0YPatqsdpduLZcsnRcSonlS9VW/Sx06NaGBTp2bUXaFaRMIW7f+O/TH3rW9ywd9CaLEyIiR/YUlfPr0cdr08e07ft+8Zd3pv0148ULzBBZajk/9yuvWr9J9rkqlatykxoo/Fyb0FhEoTNSqWXfjprXCS6ooLV+xgCIIfdDosUPOnTstjB88tCd9R/03jh0/bMCg7sL3WvvPSmHk8+dPhS9I33rZ8j8iIyMT+YlMIcVe2WZEJer1m1fCcEKbgH5VmmfW7KlNmtVi2sTalKljaU4af/LUf5QY8fapqFvggYO7aes0bFyN/m7ZukG4UUMiGzGhD03Eu3dvr1+/2qljD714rVGwQOHmzdru2bs9MCiQac8MaD3PnDnZtHkdKs9UPO7cuak///4Du+hEtnjxUpUrVTt8ZB8TRTo9C5DLFsdwyFab6Y5f/v4v6K+nZ0amPTccOWpAeET4ooWrp06e/fjxgx+H96EdgGpPv02fTzOsX7dz2pQ5NODo6Lhn3/b8+QvNmrnYzdVNtzQKxD+O6Ot37fKPw8atWrkpXdr0AwZ283/1knLl31WufurUf7o5L10+Hxoa6l2nQUJvYaLQpwQEfHr27AkNL1g4k/bwFs3bbVi/u2YN70mTR504eZTG167pc/nKBV2oDQ8Pp/Rl3ToN9JdDZxWDBv9QonhpStC3a9f16H8HaGmJ/ETMFJK8NFzJmanHCCWpPDNkFIYT2gQH9vnS359GTti98zjTFqfHTx7Sv+lT55YsUUZ/aUeOHpgxczKFzg3rdvXqOZCWtmiJpgQmshET+tBEXL9xlWkLT/xJVarUoO175/YNGnZwcLh1+zrF4mVL/9m/97Szk/NvMybp5qRjycFDe+rV+56GfXwaX7t2hY4EzEScpnBI5ZiOXLY4hkO2Uslxye4LRNXnhYtmUXqaYhO9PHJkv6ODI0Uiyi3QCe/IERMePLx32vd4/DdSRSBNGo/BA0eWL1fJQe/hODdu+FHldNzYqVThpSbB/v2GpfFIS6fJTJu1oAYrXf3r9Olj9BH58hVI5C0iUCMk/f3w8X1ERATtP5ToaNqklUcaD8qZ0uFh7T9/CmuiVqtPnY45ftAXpJe1avnoL4f2eWcXF0rUli1TgZbQs8cACism/UQJk9LtNb9R8cmu/X8J/rJw8ey79277+DSil4lsgjioOL1582rypJkUH9OmTac/ad++HSVLlhk2dEy6dOlpW/zQrd+OHf+jo3JCG9H4D9VHKRH6mylT5viThBL17n1M8A0LDf1p5ETaZajY05LpjJBqHsKk8xfOfPz4oWGDpjRcscJ3GTJ47tu/k5mITiGk86gJPPtRHMOBWaXiedP7Aj169IDOPXX/Rv40gGrKv/36hxB2b926VrhwMQ+PtMLMmTNnyZo1u1ABia9QwaLxR9646UehjXYt4SXtiqVLlbt2/QoNV61S09nZWahoU32EKj7e2jpRIm8RQXdSef/+HUplVCj/LVtKi338+CGd4dK+RMOnTh8Txvv6Hi9XtiIdLfSXQ9XnAgUK67oKNKjfRMhmmvQT2QPKaeiKEyWL6Mcc0P9HoVExkU0Qfzm5cuZxcXGJM5Ki8M1b1/SXUKZMBRpJP3hCG9GkD437cQnvUbrbZubImdvNLea00t1d83TjL19iHvx16NAeKsYZM2Zi2nJIZYbGMDnDsx/FMWfzo36Pkd27t165enHkyAlpUqcRxgQHf6EqEu17+m+hNnSDizLYhk5LiIqKirMEod5EO2SV72rQPkZtg1SzpoLuU7dR4m8R4bU2KZ/RM5OQ8KGMZ5wZ6OtQ5YuqY4sWz6azaQrKZ8+dGjJ4VJzZQkKCDa6DST+RPdD1GAkJDv5lyuiGDZq1aR1TL6PfiiWwCbLE63fk5Owcf+EUfKls/LVqCf2LtYSAT/TX4EZM5ENpu7MEeHpq4uzbt691+4LOe21yI6N2BqbtUWpwCWFhYb5nTtAKxykbVNR1PWqMQXkRhZRy2Xfv3u3YsSMDUyQQskVtV/0eI3ly5+vStcWSpXPHjPpFGJM+gycVL9oJ9d/ikSYtMxrVfVxdXadPm6c/UqmIqavSPkaVMjp5pCamYsVKenllTvItpqIMe7ZsOShrQelmejli+Hh6qT+DcPJLa0IZzzNnT9KBR3NCXdMnznJSpXIPCTXQrpj8n4jnFVK8lIYX2Zyt32OkQ/tu6zesqlu3IdUM6GUGbQNJQpvAGHSYpyptPZ/GNWp464/PmkWzfIMbUdyHUg2dYvHZs6cK5C8UZ9KFi2foLLBkybIsUUeO7qe/1LSj34mbjiiHDu81KWTzjJfOTZWRyxYngZCt2a7J2vOpFtmz58C6mZfWAAAQAElEQVQ/Fsz4vlELauOmMfnyFqASVqpkWV1V4unTx3Ha0BOXL19Bqm7Q7iHstEzbFyWtR0x1lZp3qB3y3PnT/x07qOt4m/hbTLJt28abN6+NHqVpEcqeLaeztuKmCyhUNaPTW+GslipctJdeuHAmIiKcMja6U12dQoWK7t6zldqdhJTR0f8O7t+/c8bvC5P/E0m0w4g5DiK0TenHmT176ry5y1mim4AyzkYuk4oHpch1S6BKN51IZcqk6XlmcCMmvt0TQolyaqjc9L+1tWrWpeO9bjy1Y2/fsalxo+ZJ9rDef2AXFW9q2tEfWad2fTqGUUpNv70ncZpatmTu3Yl+2eIY3oCcObodNGvaOm/e/DNnTxH6PLRu3YlqK9QiTyeb1K6yfMWCHr3aUTs+06bw6O/x44dvx+7VFAftQhUrVqGd9u3bN4GBn3fs3Nyvf5cDB3YJU6m2UqVKzV27ttAk2jeMeUviKFxSCyr9o5af32f+Qm1f1H5FOUSaRLto9259qd2JzkzpdJVS5yNHDZj/x++691L71fXrVy5fPh+n4VFAeym9a+68Xy9dPk/JnD9XLqTqG1WgEvmJjMRJtPnRDGtFtd1BA0f6Xbu8X7v5EtkEFFUp53vp0jnadon3t+ndcxDlqakdj352Ws6UqWOHj+yn63AZfyMmud0T0rfPUFdXt4GDu/9v8zqhUG363z+DhvyQJ09+mpT4e/1fvbxz52acUwFS17shVUeS7K+iT1PLlszNV5HLFseCd/KjRpIRw38eOKj7uvV/UUGnRN5fKzdt3Limb//Oz58/pXa2n0ZOKFigMNMmwSkUrv57WfFipYQ6VEJ+mz5/1+6tU6aNvX37Ro4cueg0uWXL9rqptWrUHX94eIXylaleY+RbEkHrIwxk9spStGgJWls6idZNbd+uK9XRNmz8+8qVC5ToKFa0pC6Pr1mTmj4UkSl2UAUt/pKp4vz7bwvoQELRh+apX+/7Xr00vYAT+YmAVK9Wm5rgli3/o2rVWvRbJbIJOnXsQZuP0g7/bkisjY6yCiuWrV+/YTUdHcPDw2gJ06bOdf6a+Da4ERPf7gmhNN2fyzds3LT2+IkjK/5cqFKpqFB17tSzVcsOSdaR9+7dTutATTXxl1moYBHKmaTUtWbJhFy2OJzBhzyunfaMV7GWw3IxkBX/B8FH1r8eNK8Ak5Lnd4J3rXjd7RdprVVKOXhwD520LZi/0qQ0tFls+P1x+sxObYZmZxKwf/9+X1/fadOmMTBFwo/rZSA/vCSfssjZ+jWZJqldu17WLNlmzJp85erFJFM35qVUctK5+Sr6ZYtj+KRMoeBUNr2TjR0/7OYNP4OTGjVq3r/fMCZPHJPisZa39btlU2p73PgEy8y6f3bo+tozbVL+1+nzqWV+xMj+1PC46d99xrcfJpNaRblsqSSzcY8RcQyXFbXaxveykcN/jkzg7oD6l8jLkCSbH239iRmanPiKBC+p1Y/Xgly58syds4xZHc8kdEhHLlscKx3epSZDBk8GVmMHabYsmbMyMAX6ZYuTYGKEx5OfwGxQnCAu9MsWJ5FOfmgxArPh0AAJsSGXLU7CPUawi8kQr7kBo2Sub/sGhUkSHBwUDo5MInC/bHHsNJdtqzjN7eIkc33bN8iKSEJ0tDo6ikkEctniGA7ZnEI6d0IHG4DCBHEhly1OQreFouoadjMwD7UkL/CBlIVctjgJ5bLV2MXkSYqbTaF5FgpqACmPk9CjH5HLFgm5bBuDyAgJ4pmEuhUgly0OQjYApADkssUxHLKdHLloNTIj8sMppXTq+5VKrZLO3YjsmdKRVypxjxF5M7wjObtz6mgVA7n54B+hdGJSkz6LkxoZGwlQq1jqdFIpH8hli2M4ZJeqkTr0C0K2/Dy+GeSRXnLJLo/0rk7O7NzeNwxSVGQY79PJ2GdjWhpy2eIYDtn5SqZzT+ew9Y/HDOTj1ZPAoPeqDqNyM+mp0DDdo2vBDFLOxlkPs+SSzLWPuF+2WFwiTcjbF7/8+Cq8VK0MhSuKeb4tWM2nN2EXD3589yJ8wKz8TKoC3kVumPk8d/FUlRtncHKSXvrGdl07/v7W2cBCFVPXaoncsexxiff62b7kxdtnkaroJJ7yqVlKAq1eiUzSEPck90TelcAkLuHub1wC9wZP8C0mrrP2sQOc8ctJ+HN5gzeeVjpw9CO7pVF2m5iHSdvtCwFndgdEhGoy26ZeqsVxnKk91DhT+jxabmYFZ+yXVXLMyEeLJFio4s7GFAqmcGS5i7k16CKt28PiftniJJH3bDEgB/0NCwgLDlMmMhtn6GkoMSP5mMdIaf8v7kwcr/nP4CL0I2mciXGCrIJx31q3+FhPrdLtWvr72JXLl86dOTtg8GAWb1Lsz4o1RfH15h36Y7kEHgPDfQ3IvN48cT9It256C+G0X0H7m8QNC9zXrx7nsxQKVYbMrkwOilZMV1R7xvbeP9LUQ7WCV6o509pXOHqT0XdciVWKDPH19b1z+06v3r2MmVmfktF6GzWzgufUxt3yUMkUKmO+mkrl4aWU5jkNctniGNVU5ZrO1dWGUiPczeBw9iFjVpybp5iM2cT9+EqWcjinoCgOxcZs0C9bHHu8lCY6OtpqT9sDm4FiY17oly2OPV7ggH0PRECxMS/0yxbHHotgVFSUo6OEejuBLKDYmBdy2eIgMQJgFBQb80IuWxyEbACjoNiYF3LZ4iCXDWAUJEbMC7lscRCyAYyCkG1eyGWLg+ZHAKPgSG9eyGWLY6e5bGdnZwZgCoRs80IuWxwkRgCMgmJjXshli4MeIwBGQbExL+SyxUEuG8AoCNnmhVy2OKhlAxgFxca8kMsWB7lsAKOg2JgXctnioJYNYBQUG/NCLlsc5LIBjIJiY17IZYuDWjaAUVBszAu5bHGQywYwCoqNeSGXLQ5q2QBGQbExL+SyxbHHIqhSqbDvgakQss0LuWxx7LT5EfsemArNj+aFXLY49pjLRsgGEVDLNi/kssWxx5BdoECBAwcOMACjHTt2zMPDI126dAzMJCAg4P379wxMZI8he+LEiWnSpKlUqdL69esZQKL8/Py6d+++d+/eWbNmpU2bloGZFC9evF69egxMxPE8z+wSnecuWLBg3759gwcPbtasGQOI7enTp3/88UdQUNCwYcNKlCjBACTAfkO2gM7OFi5cSGk1Ctze3t4MgLHAwEAK1teuXRs6dGiNGjUYWADtdHfv3u3YsSMDU9hjYkQfZScpT0JR++DBg507dz5//jwD+0bnXi1atChVqtTWrVsRry0H/bLFsfdatr47d+5Q7Far1VTjLlasGAM7s27dOqpcDxo0qFu3bgwsjEL2p0+fihQpwsAUCNlxXbx4kQK3l5cX7bq5cuViYAeodZGCdcOGDSkTolDY+6knSBlCtmH//fffokWL6OyYAneGDBkY2ChfX1/KhBQqVIiCNTa0NSGXLQ4uDTCsjtauXbs6dOhQv359SpU4OTkxsCGUSKWatbOz8/Tp0/Pnz8/AupDLFge17KRt2LCBUiXdu3fv27cvA/l78+bN/Pnz/f39qWZdvnx5BikBuWxxELKNtWLFitWrV1OepFOnTgzkKTw8nGrWJ0+eHDZsmI+PDwOQG7S0GKtPnz4nTpygqgHt6pQwYSA3dND19vbOkycPNTYiXqc43GNEHIRsE1A6e/jw4Zs2bbp69WqLFi2oiZKBHGzevLlatWp0QkmNjW3btmUgAchli4PEiEjPnz+nBDcVO0qVVKxYkYEkHTp0iDIh1atXp7S1q6srA8lALlschOxkuXXr1qJFiziOo8BdtGhRBpJx6dIlamPMkSMHBevMmTMzAJuAkG0G58+fp8CdJUuWwYMHU4xgkKIePnxINevIyEhqY0QlTrLQL1sc9Ms2g0paR48epZBdtmxZ+osbK6eIjx8/UrC+d+8e1ayrVKnCQMKQyxYHtWwz27lzJ+W4GzVqRIEbz52yGrVaTWmQAwcOULBu3LgxA8lDLlsc9Bgxs2bNmh05csTLy4uavP78808GlrdmzRo6y6HfnBobEa/lgrYX4rUICNkW0alTp3PnzqlUKjo9//fff+NM9fb2njFjBgNT7N+/n46CcUbSOU2dOnUCAwMvXryIS5zkBf2yxUHItqB+/fodO3bM39+/fv36u3fv1o2nEHP48OETJ04wMA6dQS9dujQsLEz3/KCTJ0+2atXq2rVr27dvHzJkCAO5QS5bHOSyreHDhw+LFi26ceMGJbinTJkSFBREI7Nly0YVcDc3NwZJGThwIJ21cBxHw6tXr6a0dZo0aShtnTt3bgbyhFy2OAjZ1vP06VNqmaR6t3BHZmoxq1mz5rx58xgkilLVK1asiIiIEF46ODgsW7asdOnSDMD+IDFiPVQlpKqi7g76NHDp0qW1a9cySNjDhw83bdqki9ckKioK8doGIJctDkK2VVE2Ns5Lyo1QVGKQgF9++eXNmzf6Yyg9gm4hNgC5bHGQGInr/KH3N04GRkUwVTSzw5+GssV2+K0dlEyhZJnzOjfri4tXrQS5bHEQsmO5efbzqe0fchV2y1c2jbOLdj/W/Eaa/5heONOPazSF57RDvHaCbmrMy5hX32bTm5MlECJppJpqk1+nxJ5H7xUtkdObovdSoVmC3nv0P93Q5377ajFfNu566X6EhJYQ+6vF+oUMzKj3CyS5SMM/UbxvxJI63iQ2NZo9fxB0//JnN3fHjqPwwE+QLoTsb/asfOn/KLzjGDxTyn7tWvYkIkTdY0o+BhaGe4yIg1z2N8/uhjfqk5OBHWvaL09UFH9862sGFoZctji4LVSM41veOjop0qbHM3ntXfrMzs9uh7NWDCyqbNmy6FYvAkJ2jC8fo5QOyBEBS5XOOfBdFAML89JiYCIkRmJERyuiIzgGdo+PYpERagYWhn7Z4qCWDQApALlscRCyASAFIJctDkJ2DIWCKRyQGAFNX3ylAxKGFodctjgomjHUaqaORvMjMLWKqaKRy7Y45LLFQS0bAFIActniIGTrQV4EwFqQyxYHIVsP8iJAB24Fr1Dg6G1xyGWLg1w2QCw849Q4eFsectnioJYNEBs1PeJeaZaHXLY4CNkxlJpOfgwArAO5bHEQpWKoNJ38GABTqBUcctkWh1y2OMhlA8Sh4BGxLQ+5bHFQy44h4urHzVvWL1ka6/nonp4ZCxQo3KvHwLx5k3hOwtZtG5cum3fk0HkmZ9HR0Xv37bh46ezNm9foZYH8hWrV8mnUsBmnraVO//XnN29fL/zjL2YOzVp4t2rZoWuXXszS1IxH+6PlIZctDkJ2DNFXP06bMsctVSqmjV937tw8dHjv8JH9/ly+IWPGTMymvX7zaszYIR8/vm/dqmOD+k2Cg7/4+p6YPWca/QgjR/zMABKFXLY4CNnJVaJkmTSp0wjDFcpXbtqkVcvW9Shwd+r4A7NpfyyY8fbt66WL1+bJE/PYLQrcR/87OG36+O8qkBi5gAAAEABJREFUV69atSaTKY7HRVVWgFy2OAjZMehUnjNHYj9t2nTp02d4/dpfePnp08clS+fevHUtPDy8QoXvunbulSOHgafBHji4e9furU+ePMyTJ3+d2vUoA0C5hcFDe7q6uM6csUg329jxwwIDPy9Z9PeTJ4927d5y5erFN29e5c6Vt1Gj5s2athbmad6y7g/d+9Fsa9aucHV1rVD+u0EDR2bI4EmTgr4ELV/+x779Oz080pYvV6l3r8FeXpmNX0l9tPyLF8+2b9dVF68F3nXq09+SpcoKLx0dHP38Lk//7efPnwPy5ys4ePCookWKM+0ZyV+rlpw7f/rduzfFi5du0axt5crVhLeoVCrKONHK03DRIiW6d+tbokTpOJ9Oy/xp9MCBA0Y0b9YmkUVRLoW+y8nT/12/fvXo4QsKhXEbmOM4ND9aHp79KA6aH2PwPGUwWfIFBwd//PiBktpMG31+HNHX79rlH4eNW7VyU7q06QcM7Ob/6mWctxw5emDGzMkFCxTesG5Xr54Dt2zdsGjJHBpfu6bP5SsXQkJChNkonl66dK5unQY0vHjJHIqYQ4eM/v23BRSvqcJ77ryvMJujo+OmTWspPO3YfnTN6q03bvr9vWY500ZJymN8+Ph+7pxlgwf99O792zHjhtBII1cyjlu3rqvV6sqVqsWfRFE7tXtqYfjtuzd0aBk3diqtZ2RU5KzZU4THQy9YOJO+Zovm7Tas312zhvekyaNOnDwqvGXFnwt37tw8ZfLsn8dNz5jRa/TYwc+fP9Vf/rNnT36eOLxp09YUrxNfFP0Ue/Ztz5+/0KyZixGFpQa5bHEQsmNwjE9+LZsi3aRffnJwcKhTW1PZvHHDj8INBaxKFatQ1bt/v2FpPNJu3Rq3lXzfvh0lS5YZNnRMunTpy5ap8EO3fjt2/C8g4FPNmnUpLJ46/Z8w22nf4/SS2vdoeMKE32bNWkIzlyldnurXhQoWuXDxjG6B2bLl6NypB8VNqlxTLfv+/Ts0kuqhlGUe2H84vYWiKlW98+UrSPVrI1cyjvcf3tHfTJkyJzHb+7c//jiOPrFc2YotW7R/+vRxUFBgRETEwUN7OnboTkkkjzQe1FzpXafB2n/+pPkDgwL/t3ld+/bdKMVEqRXKiZcvV/njpw+6BdLhcOSoASVKlKEvQi8TWRTTVpfTpPEYPHAknVKYELLR/GgVlMvu1KkTAxMhMRKD8pfiatnNmtfRf1mkSPGpk2fnzJmbhqmGSxU9CqzCJIoapUuVu3b9iv78FIUpI9G1S2/dmDJlKtDI6zeuUp2R5j91+hjliGm8r+9xCnwUVbWry2/btvH8Bd8XL54J78qSJZtuCQULFtENp06dJiQkmAYePXrg5uYmrJhmngKFfx43jQYo5CW5kqLRUUFX4/ZIk5ZpzxXoCBEZGUnHEt1s9In7D+yieP30ySN6WbhwMWE8HfymTJ6lW7GIiPBRYwZRFJ404Xchy0FHo4QWRRGcXhYqWJSBJCGXLQ5CdgyOiWx00vUYoTrsnysX9e09pNTXTG5w8JeoqKja3uX156dkt/5Lijg0D2Vj6Z/+eKpl01+qUy9aPJvCnFKpPHvu1JDBo5g2yo8ZNzQqKrJ3r0GlS5enmEhZ71jfxVCNkgK3s7NL/PHGrGR8GdJrkuPU/ChkwxNCMTf+WtEn0t8460wCPn0UJrkYWk/KqFAFnDI5RYuWcHJySnJRQsjWzWkCjiGJYgXIZYuDkB2DU3IKpZg9VddjhE7/KarOmTedMsJCqKK8BDUATp8Wq++2UqHUf+ni4kKV33o+jWvU8NYfnzVLdqYN2ZSrPXP2JIUeTVakpiYrcv8BFfVbs2ctoUq3MDNFroyeSfQpdHNLFRYWSguJ0wpnzErGR3GT/p44dZRSOnEm/bPur1o16ybSgJlBm+gfMXw8JXD0x1OahVopaSA0NMTgGwsUKNyn12BKwVPqg5olE18UE43j0WXECpDLFgchO4ZaZYan0owc/nOPXu3Wrf9LCCiUFggLC6PwkS1rdmGGV6/903rErcDSbF+Cv1DEF15Snff1a/9MmTTnjFRVpLh84cIZyglUrVKTgjvT9tagv7oYTQli+pcnd77E161woaJUW793/04RbdqBshNz5/86eOBPRq5kHJSf8fZusGvXFp+6jWjJuvHHjh9etXoptb4mErKzZ8vp7OzMtAc5YQydUlAlmr4dNRXS0Y7SMkW0HUto5Njxw6gZtn797+kltXaWLl2uX99hdBirWKEKHTYSWRQTD/HaGtAvWxw0P8bQXP2oZMmUK1ee5s3bbvj3b6HHBUXbihWrzJ499e3bNxRnd+zc3K9/lwMHdsV5V++egyhPvW//TqoCU2PglKljh4/sRwkTYSo1Ql6/fuXy5fNCwyPJnSsvxbVN//sn6EsQRd6Fi2ZRY92bt68TX7fy5StTVXTFigWUHL946dz8P35//+4trbCRKxnfj0PHUrV3yNCea9b+edXv0rnzvpOnjKGV/+676vXrfZ/IGyme0iGNasr0Zelrnjh5lFoUaX1okru7Ox0Ddu7cTPloWiZ9NfriQvjWad6sTaVKVSdPHRMSEpLIosTDnfysghLZRYoUYWAi1LJjaK5+VLHk69G9/9GjBygCzpur6Vr32/T5u3ZvnTJt7O3bN6jiWbduw5Yt28d5S4kSpVcsW79+w+rlKxaEh4cVK1py2tS5QuWRUDJk7rxf6SXVsoUxlD4eP27amrUrqOWTovD4sVM/fvowYeLIbj+0XrN6S0IrRlF+9swlv82YOHHST/SSAutvv/4hJHCMWcn4UqVK9ce8P3fv2UatoNt3bKJwXyB/oVYtO/TrOzTJHtDt23Wl2v2GjX9fuXIhVSp3+sojvl4wOXTIaIq5c+ZOV6lU+fMVnPLLLF2Tqc6Y0ZN79Gw7c9bkyb/MTGRRIGXIZYvD8ahQaO1Y/Ordi/AOY/MysG8nt7x7didowOz8DCxp//79vr6+06ZNY2AK1LJj8DgbBoGZroOFxCGXLQ5CNhhGGfl///3b4KRcufMuWrCK2SqOoQXSCtAvWxyEbDCMstJNmrQyOImz7YiGqx+tArlscRCyYyg4HqfD+py1GIBloF+2OAjZMdQ8Z5bbQgGAMZDLFgchOwZVsblk98sGm4CsiDUgly0OcgExqIrNm6NfNsgeHbwVaH60ODz7URzUsmMoFJwSPwYQNYfmRytALlscRKkYajWvimYAYB3IZYuDkB1DqTT5CesAIBpy2eIglx1DZY47+QGAkZDLFge17K80N0lGyAawEuSyxUHIjqFQUm4E5xzAOIVaiRSZ5SGXLQ5CdgwXd47ncC0NsIjwKAcnnG9ZHHLZ4qBeGaNM7XRREdhRgQW8ifbM5sLAwpDLFgchO0am7K6p0ip3LX3CwI49u/85MkzVrG92BhaGXLY4eMRBLBtnPwv+EtViUE4xT+YGmTu57fWzWyF9Z+RRKnHvAoujkP3p0yc8S8xUCNlxrZ/1+PMbtdKRqaJY4vdN5gzdjYLjYj0qIc5LlvD8Cc1pzBJYws9nMH4FBArNpfvfvjWX6B03hPlEFCD9D42/homsc6K/Of9tKh97clK/g4MTFx2hdnZjP0xGvAZJQ8g27NLhDyFB6sRvDM0bdSd8zjq3Gbp61S937lzp0qUz/a2x1zDu+ia2/vzX44WhSYn/OJxKrdq3b593nTomPQ09gcVyBw7sDw0NjY6OVmvLM6fpsKkZcFA6tG7dKsnFOjqx3KVTZcmRnOeyg2lwv2xx0GPEsPI+nkw+/vzzz8bda+fPL7PHFRau1mD//v09WvVgyVauQcvOnTu/ePFCf6Raraa4wECSkMsWB7VsSHlTpkwZMGCAp2eyDpNPnjwZPHjwmzdv9EdeunSJgSQhly2O8pdffmEgWz///HPq1KmzZcvG5Cx37txjxoxp0aIFSwZKCuXJk+fixYuUIRHGODs7r1y5MiAgIEuWLKJSRmBB7u7uGTNmZGAi1LJljHLBxYoVy5UrF7MVhw8frlmzZnK66+zevXvevHlBQUFUsC9fvhwZGblt27atW7d6eHi0bNmyUaNGDKQBuWxx0C9brsLCwurVq2dL8ZrQEYhCdnBwMBOrSZMmHTp0cHFxEVo1Kfq3b99+8+bNgwYNOnv2bLVq1ebOnfv06VMGKQ25bHFQy5alUaNG1a9f39vbm9kiIR+dOXNmJhYlxydOnBh/fHh4ONW4qd6dIUMGqnQ3aNCAQQpBLlschGz58fPz8/Lyovwss12U2aD68v/+9z8L3YaCciYUuE+dOkWBu1WrVjly5GAAcoCQLTMvX76kdpu0adMyW0fpkTNnzlDyh1lMSEiIkOmmGj3Fbot+FsSBXLY4yGXLCZ3sX7t2zR7iNdP2KBBiaPfu3f39/ZkFpEqVqkuXLjt27OjZs+exY8dq1aq1YMECOigysDzkssVBLVs2Xr16RU1qdhKv9b1+/XrFihWTJk1iFkb1eiHTnS1bNqp0161bl4HFIJctDkK2PFDlOl26dDlz5mR2bPXq1c2aNUufPj2zsPPnz1PgvnjxopDptu1mA5AXhGwZmD59OlVGKHww+0bpEUqSHDhwwDp3bgoMDBQy3blz56bAXbt2bQbmg1y2OAjZUhcZGalQKBwccDeYGNHR0bdu3SpVqhSzlrNnz1Lg9vPzo8BNB048S8Us9u/f7+vrO23aNAamQMiWtBMnTlA+pGTJkgz0fPjwoUGDBlTdTuZtSUwSEBAgZLoLFChAgbtmzZoMkgG5bHEQsqVr2bJlWbNmbdq0KQNDbt68WbBgQes/jOL06dMUuKmmL2S6rXnYAEDIBhmjJEn9+vXXrFmTPbu1H/1FNf1tWlRPpMBdrVo1BqZALlsc9MuWoj179lBKhEFSKMVPyYqjR48yq6PKdZ8+fSg506JFiy1btjRs2HDlypV0ps/AOOiXLQ5q2ZKzc+dOV1dXXIlnqokTJ/br149SSSwlvHv3TuheQu2ilDCpUqUKg0Qhly0OQjbYiDdv3vz8889U1WUp6vjx4xS4nzx50lLLDi99AotCyJaQjRs3Ojo6UmKUQTJQsoIyy+7u7izl0PFD6F5StmxZ2qCVK1dmEBty2eIgly0Vvr6+OXLkQLxOvtKlSzdu3Dg5N91OvsyZMw8cOJCS7JTjXrduXZMmTf7++++goCAGXyGXLQ5q2WCbKLkcHR2dUqntOF69eiVkuitVqkTZkooVKzK7h1y2OAjZKW/VqlVhYWFUKWNgVlTR9vb2pkBp/S6ACTly5Aitz+vXr4VMd8pmb0COELKNpVarmQU8ePAgMjKyWLFiujGcFgNzoIr2iRMndI/vsdBGVChMSzC+fPlSyHRXrVqVAnf58uWZ/UEuWxyEbGNFRUUFBgYysxIiSJwd3k2LgVl17tx5ypQpadKkYeZGm0/0zQUPHjxIgfv9+/fChZSurq7MbuAeI+IgZBvL7CGbkiEqlSr+qTFCtgn81icAABAASURBVCVQ2nTp0qV9+/Zl5packC149uyZkOmuVasWBe4yZcowO4BctjgI2cYyb8imYE1/Dd5EFCHbQuichmJEaGios7OzGW/fmvyQrUMVTwrcnz9/Fm4ZSOvJAGJDyDaWGUM2xWv62RO6nypCtoUIIZv+Ukw043MSzBiyBU+ePBEy3T4+PhS4rXmbWWtCLlsc9Mu2tjAt3P86pQgRlg6ZdAyWZn0lT548I0eOPHPmTIUKFf7444927dpt2rSJ2lGZbUG/bHEQskVauHBhixYtAgIC9EdS9blPnz6DBw9O6F0UI1xcXNC1K8VxHEe5kXXr1jVo0IA2ZZypvXr1Wrt2LUtp33///apVq6ZPn07J7mrVqk2ePPnmzZvMVpQtW7ZTp04MTISQLVL37t2dnJxoj9IfuWvXrpcvX/74448G30IVJarZoQOfRFB1O1WqVBS49+7d+/jxYyZV+fPnHzVq1Llz56hZcvbs2R06dNi8ebPQFiJrXl5eaHsUASFbpNSpU/fo0ePw4cMPHz4UxgQFBVHVrEmTJnnz5o0/f7iW9e/HD4nLkiVL8eLFqaIt/SDYtGnTv//+m+rajx49+u6776ZOnXrr1i0mW5TL3rBhAwMTIaMqXv369ffs2bNo0aL58+cz7UWMlPTo1q0b01ao16xZc+HChXfv3hUrVox2Nt01yjRyy5Yt9+/fT5cuHU2iuG+FR4ZDQiIjI/v37z9w4MBjx47VrVvX4DwUWejY/PHjx4wZM5YsWZISX6ZeO2NGBQsWHKO1Y8eOGTNm0JFG6NPN5Aa5bHFQy04WyoFQ8BXq2gcOHKBEttDZY8mSJdu3b6dITYFbqBCdOnWKxtNsEydOLF269IoVKwYMGEDn43PmzGGQQihJpVar8+XLR0dfOkOi8E2nSnGq2zR+9+7dvXv3psBNx+OTJ09u27aNSUDz5s1p3SZMmHDv3r3y5ctTyvvu3btMPpDLFgchO1koB0JxefXq1UuXLi1VqlTt2rVpZERExJEjR9q2bdu4cWOqd9eqVYvGC+eAdCZLY9q3b58pU6YKFSr89ttvNBuDFMJrMW3LxJcvXyhHTC3D+rcApGEaSenjKlWq0KQaNWrQ5v7333+pTYJJQ+HChceNG3fp0iXKC0+bNq1Lly5U+2ZygFy2OAjZydW1a1eql1FNZ+jQocIY4bYh5cqVo2FKXlMbF51NP3nyhGpwlAmhjDZVtKmm5u/v7+HhYau9buWFklRCs15AQABtFKZNbTHtzUAoOlNY1M1ZoECBkJCQV69eMYmh9Mi6devGjh178+ZNqg1IP+dAp6d08GNgIuSyk4syIRR2nz17prvPJ+3S9HfEiBFx5qRwQK3/lCQ5ffo0Jb4pN1KmTJnOnTvr3xMKUkqLFi3279//559/UpqYaS9Mpe0lPMtR/ypE4TYgYWFhTJKKahUqVIjaS6hmwKSKDoRUxaEfnIGJELLNL0OGDPSXSiTV3aidSrfDU+MV/a2gRXVzajGnc9hJkyZt3LgRV9akOEdHR0pYT5kypUmTJrTVKM2dJk0aOkNi2t4+utlCQ0Ppr/RbjCXeN4l+bcRrcZAYMT+qbgthmnIj1MZCdfCcOXPmyJGD6uPXr1+/ePEi04Z1Hx+ffv36UbaUms4ZSAAlrGljUbOEEO+ook1tFfRXP8lAGTBKant6ejIJowS9lLv///XXX+/evWMgCkK2+VFopnTH+vXrafdWq9WnTp2iBqLFixfTJNr5qWV/3759nz9/pvb9nTt3UuymdhgG0kAH0UePHumurEmdOnWdOnUo5Xru3Dlqn6RW5V27dlHWOAU7+RlDyiGb0jXFixen5ncGouB83CLatGlDFTTKeFC1mk6uqWVcaJykvZ2C9bJlyxYsWEBVuZo1a86cORNZEenIkydP48aN9+zZoxtDQZwC9O+//04NklmyZGnXrh1tXCZtUg7ZlHpikAy4k5+xRNzJT8h7mnpbPtzJz0KEO/kxsYKCggw+IcHsd/JLPjot8Pf3HzlyJJOS8+fP0x4hdIQF0ZAYsSCqR1MzCwObQClsyo0wOZBgLfvEiRNHjx5FvE4+nJJbEDIetoRq03K5BaMEQ3ZNLQbJhlq2BUVqMbAVQhxMTnbFOiQVsqnxJv7tbUE0VAMtSKWFu/fZmHTp0lFOVsrtDdIJ2dR+0LlzZ/3mXEgmhGwLokQ2ciO2h6Khq6srBSPJdvWTTsimnwjx2rwQUIxFhc/U+rK4+jWivIWI2IKJ27VrV9OmTc345F9zkUjIXr16db169bJly8bAfBAdjEV7psE+Xonw8/N79+4dlVoG0mDqFkxc69atT58+ndBdtlOQFEL2r7/+Su2NiNdmh+ZHC3r27Nm5c+cY2CgXF5c6depcu3aNSYwUQva4ceOqVq3KwNwQsi2oVKlSDRo0YGC7KNlCW7l8+fJMSlI2ZJ85c+bw4cMMLAMh24Jy586te34Y2LCLFy/ev39fOhcSp2DIPq3l4+PDwDIQsi3o9u3be/fuZWDrKD4WLFiQWiMl8rSaFAzZ1apVGzVqFAOLQci2oJcvX1KNg4F9aNasWfXq1ZkEpEjIDgoKmjt3LgMLQ48RCypatKhcLnEGs6DW5sjISIqY+g+ysb4UCdmdO3em8wwGFoZatgVlz569SpUqDOyJk5PT2rVrU/YGUilymQ/itXUgZFvQo0ePtm7dysDO9O7du1evXizlWLmWvWrVqhcvXjCwCoRsC3rz5s2JEycY2J9NmzYx7R2RWEqwZsieNWtWoUKFcuTIwcAqELItKH/+/O3atWNgrxYsWJAit/2zZsj+6aefcMmMNSFkW5CXlxdKsz2bOHFiinSisE7IPnv27L59+xhYF0K2BT1//nz9+vUM7Ni0adOYNkXGrMgKIfvcuXMnT55s1KgRA+tCyLYgOin+77//GNg9CtzWzJBYIWRXrlx59OjRDKwOIduCcubM2blzZwZ2b9GiRdu3b2fWYtGQHRwcPHPmTAYpBCHbgtKnT4/nk4KgZ8+e9Pfhw4fM8iwasn/44QdqcmSQQhCyLYgymKtXr2YAX40fP94KPf8sGrI3b94stWcB2xVcsG5+HTt2DAwMpGIdFRVF+6dwNU1ERATuSAmbNm06dOhQrVq1dM/HoeHjx48zszJXyF6zZs2yZcvOnj0rvFy5cmWdOnXy5s3LIOWglm1+9erVe/fuHVWxP378qFKp3mh5eHgwAG3xoIJx69YtGq5Ro0ZQUNDEiROZWZkrZF++fJmqGhUqVGDaPuYFChRAvE5xqGWbX7t27fbt2/f48WPdGLVa/d133zEArSxZsowePfrly5ehoaEKheLatWvUpmfGO4iZJWTTseTZs2e0erS0MmXKXL16lYEEoJZtfq6urm3bttW/l1vOnDmbN2/OAL568eIFxURhOCAg4MKFC8x8zBKyb9y4QQcSYVipVJYrV65Vq1YMUhpCtkVQ4c6aNavuJRX3fPnyMQAtygjr3+ovJCTk4MGDzHzMErKpWk1NMrqXtECqdOPZ0ykOIdsiqHx36NBBqGh7eXm1adOGAWi1aNGCYjTlynRjqLTcu3eP6trMTMwSsimRrVtJGqCKNtVCatasySBFIZdtKS1btty4cSNltEuVKlW4cGEGoLV9+/a9e/ceO3bs4cOH1ExN7XsUXqlBknIj9evXZ+aQ/JBNefb3799TIpuCdYYMGbJnz96wYcMGDRqkSZOGQYripPOM0YRsnvf888dIVQRTqb+VQiqQ+itu0kv9MbREXvOXp1EJzRNrpHb+uCMTmpPnNTebVyq0r5KYP8lJsVY7ZoDXX3Li7zV+HgdHTunIZ8ji2GJATgaMXTr24daZLxHB6qhIA1MNFgmFgvFqZvCXjjU/r6UdQeM5hdLA/HqbjBarq50nUj6p3GmKBacwuJA4I2P+xJmTFkFfQHMCoPkf/dEUNSXjVQkuUDeGvo5CuzfF3Q3j/VBOTrxrGofvmqTNVzwtA+NIOmSHh6lWTXzinlaZMYerg4PSlHpDnOIRt7QIxUkYiimznMFdLx4+TvhNZE5O+4fnkl49EYQjAov9mxi/colScKFfIt6/CI+OYH1/t/cU/PEtb+9d+pIus3OGzM68wY1p6FfXbuAEtnKCWymhUvFtfJzwmohvJTzpOY1YIq8J2rHXL/7axoyJVywTXCU1z396FRbwNqpac88SVRG1jSLdkP3uedjmP/yb9c/mkdGVQUq4+N/r++dC+s3Iz+zVlj+ef3od2WGs/f4C1rFu+sM8Rd0adM/KICnSbX7cufxVgXKpEa9TUIU6WdJncV4z9SmzS/cufPrgj3htDZ3H5390IzQyLJJBUiQash/c+BwVyX/X2ItBiqre0uvL52hmly4eC0ydHu3zVuKamtu32qp3FZcpiYbs1w8jHBzRATHluXs4KTj2+HYQsz+RoXzq9E4MrMI1lWNwoHTb1aRDopUIdaQiKlzNQAJU0YxT2+PhMzKMV0XglnVWEh3JIrHLGwHnfZAUjuFmm2BpnEK/UyIkCCEbksIz6XfeB7nT9AJHMTOCREM2r+m8z0AKOE2Lhz1uDI6y+EqUQivRnsnh106aREM2F3NFGKQ8ntnppuDVPFOhFFqJQskrHBCykybVxAiOuFJin8dPjsNt06yHWrlVUThAJk2qIdtuq3YSpDl22mPo0mRW0YXBWigxosAB0ghofoSkaI6d9hi6kFy1Ju091BgkSbKJEQ4dy6SCY8xetwXKoNVw2OWNI9nECI+OZVLB22nvK00TOOp9VsQjD2UE6TY/4ogrEZoMo132ddN08kMhtBbtbcPxcycNPUYgCZoMo132deN5hBCr4jicWCdNqiFbjXNSyeA0TxlhdgkhxGq05zQ4RCZNot1qNA9zMfGQu3nL+tre5XX/6jes0rdf5w3//i2FnHiTZrV0K9a4SY3BQ3tu3fqv2ogG8q3bNnr7VBSGm7esu/aflfHn+fw5gBZ77PhhZiE849R2G7uM/eK0NevWq7T672X6I1f+tZg2zbNnT/RHtu/4/eQpYxJZlP5GN4n/q5cLF8/u3aejT/3K7To0HjNu6Llzp5lVTP/1ZyrVLBk43R9IlGSvfuTEnZVOmzLHLVUqGvjw/t3lKxf+XLkoMjKye7c+zLqePHk0dvzQjRv26MbUqF6nefO2NPDmzSvakRYtmfPS//nQIaMTX07RIsW7dO7FUpqd1n54Znx2VaFQFC1a4srViz9076cb6XftMo2/6ncpV648wpiX/i/evn3TuVOyoptBdOQeOqxXpkyZe/YY4OziolKptm77d+z4YWNG/VK//vdM8tS89nJTSIqt9csuUbJMmtQxD4H28WkUHR21Zev6bl17W7n/0L37t+OM8cyYqUzp8sJwwwZNJ0wceer0sSRDdpEixekfS1mo+hinbJmK69b/FRoa6ubmRi9p4O7dW5UqVb127XLzZm2Eea5evUh/K5T/jpnbad/jFLX/WbPd1TXB0DuPAAAQAElEQVTmQU7lylYcM3YIjZdFyMY9oYwk1euNzJTXypu3QIgWDTdr4U3piKE/9qZz1aAvmnv2+/qe6NO3E6VQ2rZvNO7nH6n6I7yLzlunTB17+PC+eg2+a9i42o/D+wYGfl6z9s86dStQdmLpsvlCsuV/m9fRy9Onj7dsXY8mde7a4tChvTSezo5nzJxMS6MPonSNwRWjepCbWypheOOmtfQpuknCG2ndWMLnyEf/O9i5S/Omzev8PvOXgIBP+pNu3bo+avSgps1qd+nWcsnSecJ3J5N+GUVfavmKBbRw+jrMeLyd7k3arjImzF++XCWq2/r5XRJeXr9+hSoK3nUaXP06hmlDdvbsOb28MtPwp08fp00fT3kSKkXTf5vw4sUz3Wz0xlev/WkqpdR+6NlWKFeJo23Kx+4aSwuZ8fvCqVNmCy+jo6Np69PSKDU3euwQ/ZwJnRT+sWBGtx9aC+nEnbu2COMfP35IpYXmbN22Qa8+HYSRZ8+eonWmYklz7j+wS7cQRwdHP7/Lbdo1pLRM/wFdb9+5yUyhUNI/1A6SJtWQbaYw8fLlc6p0pNKmShwdHffs254/f6FZMxe7ubpdunx+4i8/1avX+H8b902a8Pvbt6/nL/hdeJeDg8PNW9fo3+ZN+5ct+YcGKNCr1ao9u05Mmvg7Rerz531pNqXSISQk+Oh/B9b/s3PH9qPedepTAKUdj06N27frSrvlsaOX2rTuFGeVPn78cPzEkRMnjtA8TBTakSh1WK/e9+v+2VG/3vcLF8369n39X4wcNSA8InzRwtVTJ89+/PjBj8P70L4qfP3HTx7Sv+lT56ZK5c5MYZ+d3dQmXrBO50NUv7589YLwkrIihQoVLV6sFAXTR48eCCMpc0KVXxqg4P7jiL40z4/Dxq1auSld2vQDBnajZLRuab/9PtHHp/GUybNpCb/NmKQf0A0qWaIM5dN/njD84qVzERER8WdYsHDmlq0bWjRvt2H97po1vCdNHnXi5FFh0uIlcy5ePEvnfL//tqBRo+YUvs9pSziVGfq7dt3Kdm27jBj+M9PG6wmTRvbsMZDmrFat9sxZU44cPSAs5O27N7t2bxk3dipNioyKnDV7iknNSGoV/UNFO2lSvfmqOU7H79y5SfG0aZPWQlaE/qZJ4zF44Ehh6qrVSym/3LpVRxr28Eg7oP/wkT8NuHvvduFCRWkMZcAHDRxJRZYm5c2TP1oVLeQoKbmRNm26R48fVK6sqRdTNGzZor2r5lzUtXu3vtu2baT6r8HUOU2if7qXFStWoRLPRNm5a7NXpsxdu/QS1ocqa7p63JEj+6myQ8GaVptejhwxoUOnJnRqXKtmXfr6lEanI5CLiwszkZ3eVtHEG90olcoyZSpcuRITsqlCTVkROnJnyZz1ytUL+fIVePjwPoXvstqQfeOG3/PnT+fMXlq2TAV62b/fMN8zJ7Zu3TBk8CimDehUripVrELDVMk4cHB3QuVKp0SJ0lSfmP/H73SOxTTnl/mrVa3Vtk0Xob5CQfzgoT0dO3Rv2qQVvWzUsNnNm9fW/vMnxW56OWHCb6GhIbSeTFuiDhzYdeHimcqVqgo7ToXylXU1DzqDpL3Gp25DYTxVWeiNwqT3798uW/pPavfUNEwrP3vOtC/BX3RZyiRxCjqtQS07aVJtfhTbv6pZ8zr6L6n8USTVvSxUsKhumGqgQnnVn0TJRyFkZ8uWQ6hiEFc3twzpPXVzpnJLFRz8RfeyYMEiMevMcVmzZn/+PFb3AB1d8yPTnsOu/GvxsB97L1+6TvcpxvP3f5E7Tz7dy8KFi+mGb926Ri+FeE0yZ85Cq3T9xlUK2fQyV848IuK1tpOfXd6wR2FyCwilsymjRQdRFxfX+w/u9us3jEaWKlWOjqkU9a5oK+BCIvvGTT/a9EK8ZtrCU7pUuWvXr+gWValiVWGAgmCe3Plev/FP8tNpK9PxgOrLVAwePLy3bv2qtf+sHD1qUoP6Te7fv0O1EP0cOn0cpTUCgwI90njQKS3VJ85f8NXV5bNkyaabs2CBmBJOtXiqrNTVxmtBv75DdcP58hUU4jXxSKMpgVGRJjwxnVfT8lHLTpqEmx9FHXF1PUZIxoxe2bPl0J/q5BTz9NXg4GCqdzg7f4tfX5uMYqoMithBSpFwzHJ2dv427OJC9Q6Ds+k3PxKquVPq8MjR/dQUyUwUFBRI+VDdS1cXV90wHUvoRIHyj/rzB3z6KAw46a2qSRT22UlebXIHUap40t9Ll85RIaSCUaJ4aaYNjosWz6ZlUeAuVqyk0DxIWyoqKirOlqITON2wUCAFLq6utNGZEahWSwk6+se0ff6mTRu3bPkftWr6CJWM+P3wqGxQnB0zbmhUVGTvXoNKly5PL+PMpis24eHhFLX19xp9lE7UDeNuIZYj4QvWmRj6PUYSIVQ2w8PDdGNCtMFavzZtJGrfS/X1IBERHk5JSWPelTNnbloHykrHn6SirF6iKL1D2WrdS91hhqTP4EknyPr9zNjXKo949tr8yEy/X3aOHLkoE3LvwR1KTxUrWlKIYuXKVQoOCX769DG1DLds0U6YM0MGT4rd06fN03+7UvGtuZPio+6USJO10Kv2GkRtJBRPM2bMpBuTLWv2tm27UJszJcQyeGakMSOGj88WuxKTKVNmOhugk8vZs5YISXamPZxk9MwU/yPoIER1l4QqJcmkdOCUjrj7atKke79si4YJ2pcKFSxCu5BujDCcN18BZqKrfhcpaci06cLnL55+9111Y95F7aK0T2bWZg8dHZ3ovZQWF/bw58+eJP5eL68sZ86epP1TqPufPXdKNylf3gKHDu8tVbKs7rSAIoV+lVwMe70qjdc+HMlU5ctVfvDgLlUzaUAY4+mZkUI5nVF9+RJUrmwlYSSlEcLCwihiUmAVxrx67Z/W41stmxZCR1+m7Sz47NmTGtW9E//cMWOHUAZvzqyl+qk2alSnv+nSpacyJpwO6k71AgI+UcWf6vJC9yFdjKYCQ/8oFRP/IyhZTw2qlNLRjRGuexg4YDhLNlU0r4rCFc9Js52rH01FTefULrd1679BX4LojHXJ0rmUWCyQv5BJC6HISElAakei9iJqz6TI612nAY2nKEm1ntOnj+uSgx/ev6NPEf4dP3GETkVTp05DCW6aVLRoCdp5qImJaXv4bdj4d+IfWquWz+fPAQsXzRLOtXfs+J9uUuvWnSiUL1oyh44H9NHLVyzo0avd4ycPWXLYay1bczWX6V+ccgsUbanpW5enJnQQ3bVrC1Wrdb3sqUpLTdCzZ0+lLU5Bc8fOzf36dznwtc8cHbypoY/KFR3I/1q9hP7WqV0v8c/t02cIVTsmTBp58dI5oZgtXDybQmq7tl2obYNCMzXqUHsjNXtSkD1x8ujIUQOorZLemDtXXvq4Tf/7h3YE+kQqV5TeeaON9fE1a9KacuU0My1/564t/25ckydPPgZWZGtXPxqvXr3G7z+827T5HwpwdDJLdSLK5TETUWWqbZvOw0f2owBNO+SYUb9QfYrGV65UjfKYtP9069pHaOg/eeo/+ie8i9KFNWp4074knMYWKVysf79hK1YsmDN3OoXvPr0GDxveJ5E0Ku1R1OxDIaBO3Qq05uPHThsyrJcwPyWF/lq5aePGNX37d6bdj5oifxo5oWCBwgxMx1Hzo8LkmE2BmI6XVBgKFfrW1k0tkHv2bqczMP2E72/T5+/avXXKtLG3b9+gYkPNei1btmea7iLRbm6pqFxRMaC6cN68+X8ePz3JUyUqFQvmr9yxa/OChTMpE0JRnhrSBw0c2eJro3f7dl2pak8VgitXLqRK5U55mxEjNP32NEVo3LQ1a1dQ0z2lTcaPnfrx04cJE0dSW8v0qXPjfEr9+t8HfQmkmSkfSLmdPr0HN2rYjJkDp0AG3CicNG9LfXzT+1vnA7tOys8kbOu2jVQ3P3r4ArNpayY9+L5XttzF3ZidWTb6kVcOt7pdsjCwvB2LnkeGq3pOzcMgUVLNZSs0R12QAk1K1z4fJMYAJAc3XwUwjJfYM6PHjh9284afwUmNGjXvr+0DLmMKhsf1GkOqVz9qNp7UazmtWrZvpU0+2jz7zDEqlZykHsczZvTk6Kgog5MS6istJ3bbl9RE0r36UUTLD1gIb5dJApWKl9TjeDSXKdowhGzj2NrNV8Ei7HJnUjpwnAOiCEgLctmQBE0F2y7v16OK5vlotEFaC2enN4w0FWrZkARNPdM+79fDoaOw9WjiNXKhRpBuyMbuAilLc/0tyqDV4Kc2jmRvC8VJq4MVAFiS5oE6aoTtpEn2tlDSvCrTXtnlGQ+P5xFaE89QSzMGctlgBPsMXWrEEJAchGwAwzS3heIQs0FapHr1I6fm8CA4abDfZmCe8SiE1qK9dA4de5Mm0ZDt5MYpTX4mIliEQsmc3ZTM/ji6Ui0bQcRaOOaaBif9SZPojVjKeqeOjsQ5acp7cO0T1bKz5nVl9ietpzLgXQQDqwgNivLKjmpa0iQasl1dXdOkd9i94hmDFHX9WKBXHpEP+ZW7loNyhgWpg4PDGFjYnQuf1Crm3SErg6RI93aHXcbnjgpXb1vymEEK2TjzYfosTi0H5GD26vvembfP83908xMDi/E78e7iwU/dxiXvCaV2Q6JPpdH5e/KjsGCecqkcU0SrviUWFQpO/fUqas11kvQtFBwf+7pq3TzxL8tRUJLy6xfnFN/uZ6LpIsB/WyyvaYGKNZ7TfopugbqPEAZ04+PMQI1YNFeshSs4oe85xzjeUFeyWOusfaHQfDTTzaz/WUy7ZOFn0J+qP+brl4oZI6yM9r4OcYuAo5MiKjIqKpylzejQcXRuZt/8HwbvWvGGEvqOTpxKlVgVR6mkGfiErgFTKjhV7PIZp1AZeA9tdOW3cm7wvbFHaktCnPk5bWmPs2vQ+xXaWxXqLZDerj+b9m6a2lL9rcywOBFDoVSoY++VvOaGfHGLqP4y9cc4OqojwjWzd/s5p6u7EwMjSD1kk3t+gfcvfgkL4qP1S1isOKstCIq4d5L6FrLjRy69nSRW9I+9WO7r3TV044WBb4U49vg4RVKtVgcEfMqQwTMm0Ot9qOaZO2qDwdrALq9Q0KJirZt2vpi3a/cjzfrE/5rCG2PwwrPSv4aJr2+Jv5M7OCnc3NUVG2TMlN0eU9gGndzx/t3z0MjwxDqQKB04VXSCIVu/mAl0GzT+pPjzxF2aXp1Db2bNVlWr4y6BxN81GIsdoDltKdIvYF/HfKscaAuN/qfSkYwSGnqL1V5/pLcHJR5dXNwV2fK5VKrvycBoMgjZ8vXhw4dOnTodPHiQAQCYA3rVWFB0dLT+E7UBAJIJAcWCELIBwLwQUCwoKirK0RFdTQHAbBCyLQi1bAAwLwQUC0LIBgDzQkCxIIRsADAvBBQLQi4bAMwLIduCUMsGAPNCQLEghGwAMC8EFAtCyAYA80JAsSCEbAAwLwQUC0LzIwCYC8O9+gAAEABJREFUF0K2BaGWDQDmhYBiQQjZAGBeCCgWhJANAOaFgGJBCNkAYF4IKBaEkA0A5oWAYkEI2QBgXggoFoSQDQDmhYBiQZGRkU5OeG40AJiNgoHFoJYNAOaFgGJBKpUKIRsAzAgBxbKQGAEAM0LItqCoqCi1Ws0AAMwEIduCKCtC6WwGAGAmCNkWhJANAOaFkG1BCNkAYF4I2Rbk6OhI6WwGAGAm6JdtQahlA4B5oZZtQQjZAGBeCNkWhJANAOaFkG1BCNkAYF4I2RaE5kcAMC+EbAtCLRsAzAsh24IQsgHAvBCyLQghGwDMCyHbghCyAcC8ELItCCEbAMwLIduCELIBwLwQsi2IQrZKpWIAAGbC8TzPwNzatGlDwTokJCQwMDBjxoxqtToiIuLIkSMMACAZUMs2v19//fXRo0cKRcwtt16/fk1/KXAzAIDkwZ38zK99+/Y5cuTQH0OnMmXKlGEAAMmDkG1+efPmrVmzpv6YdOnSdejQgQEAJA9CtkV07tw5Z86cwjBVsUuVKlWiRAkGAJA8CNkWkSlTpjp16ghNu5TF7tSpEwMASDaEbEvp0qVL7ty51Wp1vnz5ypYtywAAkg2d/L45u+/D4xtfoiJZdCRTKDi1mldwHB3U1Cqe/p9+JxpJf2lQrf3NOAUNxYykn5GjHIh2OQqOCTOEh4eHhYW6u6d2cXFU81zM21jMwh0cFNHRamH463imVjOOi9koSiWnUn3bOk7OvLOrskhl95JVMzAAsEsI2TH+nPBQHc25pVE4OjpER/FCOOa0JyGaAW3I1rzU/lrCbyZEW2FOfbqYqx0W3qiJ57rZYmK9g0IdrRZmEMSE76+xX+HA1HrXTjo6cZER6uDPUWkzOXQYmZsBgP1ByNZY/csjBxeuef+8TA7+N+dhKg+n9iNyMgCwM8hls/Uznjo4yyZek7Yj8ocERu1Z+ZIBgJ1ByGaB76Ort8zCZCV/uTSvHoYzALAz9h6y7/sF0t8MmV2ZrBQq7xGNh0oC2B97v8eIOoqT4732XJyc1LhFIID9wW2hAABkAyEbAEA27D1kc5pe0AAA8mDvIZtn6JYOALJh94kRhSyr2RzODQDskt2HbLUsq9m4ZBXAPiGXjWQ2AMgGctlIZgOAbKCTnyzhzADAPqH5USHH8IczAwD7hOZHtRzDH3qMANgnu29+5HhZ1rJRzQawS/Z+Jz+e50yNfpu3rK/tXT7oS5CISaPHDok/qWfv9jTp4qVzDAAgUbhftvU4OjpevHj206eP+iMfPXrw/PlTBgBgBIRs68mUKXPWLNmO/ndAf+SRo/uLFSvJAACMYO8h25q3hVJFR1eo8N2RI/t1Y3ie/+/YwXJlKzETofkRwD7ZfS2bs1JDHsdxKrWqXr3v7z+4+/TpY2HklasXP3x4X7uWjzCD8UtD8yOAfULzI7OmIoWLZcuaff+BXcLLw4f3Ub3b3T21dk0QhgEgCXafGLFWhoHXogFv7wYHD+2h4YiIiJOnjtau6cNE4HA1DYA9QvOjtbPCPj6NAwM/X7p8/rTv8aioqOrV6zAReFyzDmCP7P62UFZPR2TPlqNggcKnTx8LCgqsVrWWm5tbZGQEMxHiNYB9QmIkBcIf5UYuXjx7/oJvzZp1mSiyvGQTAJINtWyRSeEb16+6pUqle5k+XYZcufIkOUlQ17vh0mXznZycvqtcnYmDTDaAXcLNV0X6eeII/Zf16jUeO3pykpME6dNnKFWqbEbPTM7OzgwAwGicnfctu3s56Mi6d91+yc9kRRXJ1k1/OGi+zFYbAJIJN1+VZY4BqWwA+4RnP8oy+qH5EcA+4dmP8swLofkRwC7hEQfyrGijlg1gl1DLlmdFG7VsALtk982P8ox9uPkqgH1Cv2xZwl3/AOwTeowwZBkAQC7sPpfNcTLt5wcAdgi5bFnmGJDLBrBPyGXLEnLZAPYJIRsAQDYQsgEAZMPuQ7aSd3SQX5ZBxSLxDDgAO2Tv+33hsh5qngv8FMZk5c7ZYEcnBgD2BlU1ljqD4uSWd0xW7l8OyJwbj0cAsDsI2azL2LyhQdH7Vz1lMrFlwWMnV2WzfjkYANgZe38qjc6fPz/keIVbOoWri7MqWu83UWgeg6DBaS+T1L38OqBQ8mpV7G7Swis+1myckufjz8Z9WzhtiG8X9eg+RX92BxYeGvXlU5S7h2PnsbkYANgfhOxvjm99+/xeaHQ4i4r89ptwsa9n5xSMF0IwF9M5WqlkKlW8ZQlv43k1r1IoNG28CgWnVsf6qRXaJxUY/PljPjT2Zzu6MBdXRd4yqSrXy8gAwC4hZFvQhw8fOnXqdPDgQQYAYA7ol21B0dHRDg74hQHAbBBQLAghGwDMCwHFghCyAcC8EFAsCCEbAMwLAcWCELIBwLwQUCwIIRsAzAsBxYKioqIcHR0ZAICZIGRbEGrZAGBeCCgWhJANAOaFgGJBCNkAYF4IKBaEXDYAmBdCtgWhlg0A5oWAYkEI2QBgXggoFoSQDQDmhYBiQQjZAGBeCCgWhOZHADAvhGwLQi0bAMwLAcWCELIBwLwQUCwIIRsAzAsBxYKQywYA81IwsBjUsgHAvBBQLAghGwDMCwHFghCyAcC8EFAsyNnZ2cnJiQEAmAlCtgVR82N4eDgDADAThGwLoqwI5UYYAICZIGRbEEI2AJgXQrYFOTo6Um6EAQCYCfplWxBq2QBgXqhlWxBq2QBgXgjZFoRaNgCYF0K2BSFkA4B5IWRbEEI2AJgXQrYFIWQDgHkhZFsQQjYAmBdCtgUhZAOAeSFkWxBCNgCYF0K2BSFkA4B5IWRbEEI2AJgXQrYFIWQDgHkhZFsQQjYAmBfH8zwDs+rfv//58+c5jlOr1QqFQviFPT09Dx06xAAAkgF38jO/fv36ZciQgUK2UqmkvxS16W+RIkUYAEDyIGSbX6lSpcqWLas/Jm3atB06dGAAAMmDkG0RPXv29PLy0r3Mly9f5cqVGQBA8iBkW0TBggXLly8vDKdKlapjx44MACDZELIthSramTJlooEcOXLUqlWLAQAkm433GDm7993HV1FRkZzwkuOY7utqB2PGawc5vffxTDtJoaApMT+R9r0x478uTX+SZgKv/ykce/b02ccPH3LmyunpmVE779fV0MwZa1E0Qvuub2OozZLm4dWxvs7X1edijdT7UvocXdQ5CriWqpGBAYCtsNmQ/fRe8P5Vb2jA2VkRFREzknPg+OiY78spOV4VM0zBkdPFQS5mlHYextRfw6RCO8B/nYf/Fis1k9Qxf2O/5NVqtdJBqX3J0Uu9j9B+po7ehwqUDpxaHTdka2O23qoK4zjDG9HRmY8M5xUOrPuEnE6uTgwA5M82Q/bzO8F7Vr35rnHG/GU8mH27fOjt7QtffpiS0xVRG0D+bDNkLxrxsPP4PEqlkgFjdy99vHwooN+M/AwAZM4Gmx83zXvmkVaJeK1TuHwGpSM7tP41AwCZs8GQ/eVTdLpszgz0pPJwev88ggGAzNlgyI7StLmh82IsnEIRHsoAQO5s8E5+mm550QjZsal4Xq1mACBzuPkqAIBsIGQDAMiGLSZGOM1lLKCPU3AKJccAQOZsMGRrLvRG2jY2XnMhJZ5lASB7tpkY4VChjAdPHwKwAbZYy6bEiBLxCQBskE128mPqaFSzY6FEttIRCX4A2UOPEbugVvGqKCT4AWQPIRsAQDZsMpfNKxTIZceFJlkAG2CjF6wjYsemaZJVIGYDyJ5tNknpP5FLyj5/DqjtXf7Y8cPMwjRNsiocxwBkzzY7+SnQyQ8AbJGNdvJTIQkAADYIfXXFu3Xr+qjRg5o2q92lW8slS+eFhIQI47fv+F/L1vWeP3/6Q8+2lPfo2bv9gYO7de86+t/Bzl2aN21e5/eZvwQEfGLWguZHABtggyGb4ziF5b/WS/8XI0cNCI8IX7Rw9dTJsx8/fvDj8D7R0dE0ydHRMTj4y4KFM38aMeG/Ixdr1qg7c9aUt281j3t//Pjh9F9/rlfv+3X/7Khf7/uFi2Yxq+CUHKfE4RlA9mxwN+atcjuNI0f2Ozo4UrDOmTN37tx5R46Y8ODhvdO+x4WpUVFR3br2KVq0BB0/KDTzPP/w4T0av3PXZq9Mmbt26ZUmdZoypcs3btyCWQWv4tXRuJQGQPZssZZtlRzArVvXChcu5uGRVniZOXOWrFmzX79xVTcDTRUGUqdOQ3+p3k1//f1f5M6TL/48AADGsMnmR2s8M4tC8N17tylVrT8y4NNH3TBn6MARFBSYPXtO3UtXF1cGAGA0XLAuUvoMniVKlP6hez/9kR5p0ib+rjRpPCj9rXsZGhrCrIJSRTzaHwHkzwZDtkLBKR0sns3Ol7fAocN7S5Usq/ja1vn06WP9GrRBXl5Zzpw9qVarhXedPXeKWQX9Jgq0PgLInw3ux2o1r1YxS2vduhNF3kVL5oSHh7948Wz5igU9erV7/ORh4u+qVcvn8+eAhYtmUfbmqt+lHTv+x6yCPo7H1Y8A8meDIZuqk5zln3OYJnWav1ZuomR03/6du3Zv5Xft8k8jJxQsUDjxd1UoX7lf36EXLpypU7fCjJm/jBk9mWnjKQMAMAJne/FiychHuYqmrtEqE4Ov9ix/ERIY1Wt6XgYAcmaT9xhB3jYuOi6j9RHABthkjxETThw+fHj/Q482Bie5pXIPDQk2OClX7ryLFqxi5tOkaa2EJkWroh2UBjZToUJFZ89awoyjdOAUDjiOAcieLfbL1lxNY6y0adOtWLHB4KSI8HBnFxeDkwzG0ORIaB00qxER4ezsHH+8k6MTMxoeJAZgG2yxls0z4y+lcXBwyJI5K0tpUlgHAJA+W+yXjVw2ANgom0yMoNNcXNoHiTEAkDvb7DGC3hFxaC5YRyobQP5sMGRb5+pHmeE0CSMGADJnk/cYYUrc7SoOShWpkS4CkD0bffYjkgBxUJMsskUA8meL1VE1QwNkXDyvxm8CIH+22PyoRCc/ALBNttn8qFIhCQAANsgGQ7aTM3N0RjI7FqUjc3LFqQeA7Nngbuzgwn1+H8lAT+iXSLfUOPMAkD0bDNkFyroHvEHIjiX0C1+lOW4gDiB7NhiyqzbO5OKu2DjrIQOt9b89zJzLKWsuPM0dQPZs8Kk0gj0r/V89DsuUwyVjdlfu26U1X+/MymkGOe2t/7+9RztSwXjNRSfaXsycdozwAwnDwnt06NdTcJz+CAXH1HzMMul4qBbepfuEmN/76wxcrAtcFByve692zq/D2g82vJ1ivgiLWWX+2zeKjox+9yLsw8vwsnXSVqzvyQBA/mw2ZJNjm18/vhkaHcGiI75+R10AFWIxFzsQ6gVlXbDU4GNNZXF+MP0xnDa0qrlvL2PHeE6hucyH03uvZi2+hWm9eXXhXDOS19w2Rfclvs6mWU9FzEGFi7O21OToxLm6K0pWS12mNuI1gI2w5ZANAGBjcDMOAADZQMgGAJANhGwAANlAyAYAkA2EbOYXKBQAAAAPSURBVAAA2UDIBgCQjf8DAAD//+2P24QAAAAGSURBVAMAq5YKYGLLuPoAAAAASUVORK5CYII=",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from typing import Literal\n",
    "from langgraph.graph import StateGraph,MessagesState, START, END\n",
    "from openai import OpenAI\n",
    "from typing_extensions import TypedDict\n",
    "from typing import List\n",
    "\n",
    "\n",
    "# === Define workflow node functions ===\n",
    "def retrieve_context_q_n_a(state):\n",
    "    \"\"\"Retrieve top documents from ChromaDB Collection 1 (Medical Q&A Data) based on query.\"\"\"\n",
    "    print(\"---RETRIEVING CONTEXT---\")\n",
    "    query = state[\"query\"] # last user message\n",
    "\n",
    "    results = collection1.query(query_texts=[query], n_results=3)\n",
    "    context = \"\\n\".join(results[\"documents\"][0])\n",
    "    state[\"context\"] = context\n",
    "    state[\"source\"] = \"Medical Q&A Collection\"\n",
    "    print(context)\n",
    "    # Save context in the state for later nodes\n",
    "    return state\n",
    "\n",
    "# === Define workflow node functions ===\n",
    "def retrieve_context_medical_device(state):\n",
    "    \"\"\"Retrieve top documents from ChromaDB Collection 2 (Medical Device Manuals Data) based on query.\"\"\"\n",
    "    print(\"---RETRIEVING CONTEXT---\")\n",
    "    query = state[\"query\"] # last user message\n",
    "\n",
    "    results = collection2.query(query_texts=[query], n_results=3)\n",
    "    context = \"\\n\".join(results[\"documents\"][0])\n",
    "    state[\"context\"] = context\n",
    "    state[\"source\"] = \"Medical Device Manual\"\n",
    "    print(context)\n",
    "    # Save context in the state for later nodes\n",
    "    return state\n",
    "\n",
    "def web_search(state):\n",
    "    \"\"\"Perform web search using Google Serper API.\"\"\"\n",
    "    print(\"---PERFORMING WEB SEARCH---\")\n",
    "    query = state[\"query\"]\n",
    "    search_results = search.run(query=query)\n",
    "    state[\"context\"] = search_results\n",
    "    state[\"source\"] = \"Web Search\"\n",
    "    print(search_results)\n",
    "    return state\n",
    "\n",
    "def router(state: GraphState) -> Literal[\n",
    "    \"Retrieve_QnA\", \"Retrieve_Device\", \"Web_Search\"\n",
    "]:\n",
    "    \"\"\"Agentic router: decides which retrieval method to use.\"\"\"\n",
    "    query = state[\"query\"]\n",
    "\n",
    "    # A lightweight decision LLM — you can replace this with GPT-4o-mini, etc.\n",
    "    decision_prompt = f\"\"\"\n",
    "    You are a routing agent. Based on the user query, decide where to look for information.\n",
    "\n",
    "    Options:\n",
    "    - Retrieve_QnA: if it's about general medical knowledge, symptoms, or treatment.\n",
    "    - Retrieve_Device: if it's about medical devices, manuals, or instructions.\n",
    "    - Web_Search: if it's about recent news, brand names, or external data.\n",
    "\n",
    "    Query: \"{query}\"\n",
    "\n",
    "    Respond ONLY with one of: Retrieve_QnA, Retrieve_Device, Web_Search\n",
    "    \"\"\"\n",
    "\n",
    "    router_decision = get_llm_response(decision_prompt).strip()\n",
    "    print(f\"---ROUTER DECISION: {router_decision}---\")\n",
    "\n",
    "    print(router_decision)\n",
    "\n",
    "    state[\"source\"] = router_decision\n",
    "    return state\n",
    "\n",
    "# Define the routing function for the conditional edge\n",
    "def route_decision(state: GraphState) -> str:\n",
    "    return state[\"source\"]\n",
    "\n",
    "\n",
    "def build_prompt(state):\n",
    "    \"\"\"Construct the RAG-style prompt.\"\"\"\n",
    "    print(\"---BUILDING GENERATIVE PROMPT---\")\n",
    "    query = state[\"query\"]\n",
    "    context = state[\"context\"]\n",
    "\n",
    "    prompt = f\"\"\"\n",
    "            Answer the following question using the context below.\n",
    "            Context:\n",
    "            {context}\n",
    "            Question: {query}\n",
    "            please limit your answer in 50 words.\n",
    "            \"\"\"\n",
    "    \n",
    "    state[\"prompt\"] = prompt\n",
    "    print(prompt)\n",
    "    return state\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "def call_llm(state):\n",
    "    \"\"\"Call your existing LLM function.\"\"\"\n",
    "    print(\"---CALLING LLM---\")\n",
    "    prompt = state[\"prompt\"]\n",
    "    answer = get_llm_response(prompt)\n",
    "    state[\"response\"] = answer\n",
    "    return state\n",
    "\n",
    "\n",
    "def check_context_relevance(state):\n",
    "    \"\"\"Determine whether to retrieved context is relevant or not.\"\"\"\n",
    "    print(\"---CONTEXT RELEVANCE CHECKER---\")\n",
    "    query = state[\"query\"]\n",
    "    context = state[\"context\"]\n",
    "\n",
    "    relevance_prompt = f\"\"\"\n",
    "            Check the below context if the context is relevent to the user query or.\n",
    "            ####\n",
    "            Context:\n",
    "            {context}\n",
    "            ####\n",
    "            User Query: {query}\n",
    "\n",
    "            Options:\n",
    "            - Yes: if the context is relevant.\n",
    "            - No: if the context is not relevant.\n",
    "\n",
    "            Please answer with only 'Yes' or 'No'.\n",
    "\n",
    "            \"\"\"\n",
    "    relevance_decision_value = get_llm_response(relevance_prompt).strip()\n",
    "    print(f\"---RELEVANCE DECISION: {relevance_decision_value}---\")\n",
    "    state[\"is_relevant\"] = relevance_decision_value\n",
    "    return state\n",
    "\n",
    "# Define the check_context_relevance function for the conditional edge\n",
    "def relevance_decision(state: GraphState) -> str:\n",
    "    iteration_count = state.get(\"iteration_count\", 0)\n",
    "    iteration_count += 1\n",
    "    state[\"iteration_count\"] = iteration_count\n",
    "    ## Limiting to max 3 iterations\n",
    "    if iteration_count >= 3:\n",
    "        print(\"---MAX ITERATIONS REACHED, FORCING 'Yes'---\")\n",
    "        state[\"is_relevant\"] = \"Yes\"\n",
    "    return state[\"is_relevant\"]\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "# === Build the workflow ===\n",
    "## Define the state structure\n",
    "\n",
    "class GraphState(TypedDict):\n",
    "    query: str\n",
    "    context: str\n",
    "    prompt: str\n",
    "    response: str\n",
    "    source: str  # Which retriever/tool was used\n",
    "    is_relevant: str\n",
    "    iteration_count: int\n",
    "\n",
    "    \n",
    "workflow = StateGraph(GraphState)\n",
    "\n",
    "# Add nodes\n",
    "workflow.add_node(\"Router\", router)\n",
    "workflow.add_node(\"Retrieve_QnA\", retrieve_context_q_n_a)\n",
    "workflow.add_node(\"Retrieve_Device\", retrieve_context_medical_device)\n",
    "workflow.add_node(\"Web_Search\", web_search)\n",
    "workflow.add_node(\"Relevance_Checker\", check_context_relevance)\n",
    "workflow.add_node(\"Iteration_Limiter\", iteration_limiter)\n",
    "workflow.add_node(\"PromptBuilder\", build_prompt)\n",
    "workflow.add_node(\"LLM\", call_llm)\n",
    "\n",
    "# Define edges\n",
    "workflow.add_edge(START, \"Router\")\n",
    "workflow.add_conditional_edges(\n",
    "    \"Router\",\n",
    "    route_decision,  # this function decides the path dynamically\n",
    "    {\n",
    "        \"Retrieve_QnA\": \"Retrieve_QnA\",\n",
    "        \"Retrieve_Device\": \"Retrieve_Device\",\n",
    "        \"Web_Search\": \"Web_Search\",\n",
    "    }\n",
    ")\n",
    "workflow.add_edge(\"Retrieve_QnA\", \"Relevance_Checker\")\n",
    "workflow.add_edge(\"Retrieve_Device\", \"Relevance_Checker\")\n",
    "workflow.add_edge(\"Web_Search\", \"Relevance_Checker\")\n",
    "workflow.add_conditional_edges(\n",
    "    \"Relevance_Checker\",\n",
    "    relevance_decision,  # this function decides the path dynamically\n",
    "    {\n",
    "        \"Yes\": \"PromptBuilder\",\n",
    "        \"No\": \"Web_Search\",\n",
    "    }\n",
    ")\n",
    "workflow.add_edge(\"PromptBuilder\", \"LLM\")\n",
    "workflow.add_edge(\"LLM\", END)\n",
    "\n",
    "\n",
    "# Compile the dynamic RAG agent\n",
    "agentic_rag = workflow.compile()\n",
    "\n",
    "\n",
    "# ===================================\n",
    "# ===  Visualize Workflow (Optional) ===\n",
    "# ===================================\n",
    "\n",
    "\n",
    "# === Run it ===\n",
    "from IPython.display import Image, display\n",
    "display(Image(agentic_rag.get_graph().draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 213,
   "id": "5e8b9a55",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "---ROUTER DECISION: Retrieve_QnA---\n",
      "Retrieve_QnA\n",
      "'Finished running: Router:'\n",
      "---RETRIEVING CONTEXT---\n",
      "Question: What are the treatments for Kawasaki disease ?. Answer: These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care. Type: treatment. \n",
      "Question: What are the treatments for Krabbe Disease ?. Answer: There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.. Type: treatment. \n",
      "Question: What are the treatments for Ehlers-Danlos syndrome, progeroid type ?. Answer: How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.. Type: treatment. \n",
      "'Finished running: Retrieve_QnA:'\n",
      "---CONTEXT RELEVANCE CHECKER---\n",
      "---RELEVANCE DECISION: Yes---\n",
      "'Finished running: Relevance_Checker:'\n",
      "---BUILDING GENERATIVE PROMPT---\n",
      "\n",
      "            Answer the following question using the context below.\n",
      "            Context:\n",
      "            Question: What are the treatments for Kawasaki disease ?. Answer: These resources address the diagnosis or management of Kawasaki disease:  - Cincinnati Children's Hospital Medical Center  - Genetic Testing Registry: Acute febrile mucocutaneous lymph node syndrome  - National Heart, Lung, and Blood Institute: How is Kawasaki Disease Treated?   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care. Type: treatment. \n",
      "Question: What are the treatments for Krabbe Disease ?. Answer: There is no cure for Krabbe disease. Results of a very small clinical trial of children with infantile Krabbe disease found that children who received umbilical cord blood stem cells from unrelated donors prior to symptom onset developed with little neurological impairment. Bone marrow transplantation may help some people. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation.. Type: treatment. \n",
      "Question: What are the treatments for Ehlers-Danlos syndrome, progeroid type ?. Answer: How might Ehlers-Danlos syndrome progeroid type be treated? Individuals with Ehlers-Danlos Syndrome progeroid type can benefit from a variety of treatments depending on their symptoms. Affected children with weak muscle tone and delayed development might benefit from physiotherapy to improve muscle strength and coordination. Affected individuals with joint pain might benefit from anti-inflammatory drugs. Lifestyle changes or precautions during exercise or intense physical activity may be advised to reduce the chance of accidents to the skin and bone. It is recommended that affected individuals discuss treatment options with their healthcare provider.. Type: treatment. \n",
      "            Question: What are the treatments for Kawasaki disease ?\n",
      "            please limit your answer in 50 words.\n",
      "            \n",
      "'Finished running: PromptBuilder:'\n",
      "---CALLING LLM---\n",
      "'Finished running: LLM:'\n",
      "('Treatment for Kawasaki disease typically includes intravenous immunoglobulin '\n",
      " '(IVIG) and high-dose aspirin to reduce inflammation and prevent coronary '\n",
      " 'artery aneurysms. Some children may need additional IVIG, corticosteroids, '\n",
      " 'or other anti-inflammatory medications. Close cardiac monitoring and '\n",
      " 'follow-up are essential.')\n"
     ]
    }
   ],
   "source": [
    "input_state = {\"query\": \"What are the treatments for Kawasaki disease ?\"}\n",
    "\n",
    "from pprint import pprint\n",
    "for step in agentic_rag.stream(input_state):\n",
    "    for key, value in step.items():\n",
    "        pprint(f\"Finished running: {key}:\")\n",
    "pprint(value[\"response\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 212,
   "id": "53aab084",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "---ROUTER DECISION: Retrieve_Device---\n",
      "Retrieve_Device\n",
      "'Finished running: Router:'\n",
      "---RETRIEVING CONTEXT---\n",
      "Device Name: Dialysis Machine. Model: Model 1703. Manufacturer: Edwards Lifesciences. Indications: Used for intraoperative measurement monitoring during complex oncological surgeries.. Contraindications: Not recommended in presence of peripheral vascular disease or at open wounds locations.\n",
      "Device Name: Dialysis Machine. Model: Plus593. Manufacturer: Siemens Healthineers. Indications: Used for emergency tissue biopsy in acute diabetes situations requiring immediate care.. Contraindications: None\n",
      "Device Name: Dialysis Machine. Model: Max384. Manufacturer: BioMérieux. Indications: Designed for continuous monitoring assistance in geriatric care facilities for elderly patients.. Contraindications: Avoid use if patient has cardiomyopathy or is receiving radioactive materials.\n",
      "'Finished running: Retrieve_Device:'\n",
      "---CONTEXT RELEVANCE CHECKER---\n",
      "---RELEVANCE DECISION: Yes---\n",
      "'Finished running: Relevance_Checker:'\n",
      "---BUILDING GENERATIVE PROMPT---\n",
      "\n",
      "            Answer the following question using the context below.\n",
      "            Context:\n",
      "            Device Name: Dialysis Machine. Model: Model 1703. Manufacturer: Edwards Lifesciences. Indications: Used for intraoperative measurement monitoring during complex oncological surgeries.. Contraindications: Not recommended in presence of peripheral vascular disease or at open wounds locations.\n",
      "Device Name: Dialysis Machine. Model: Plus593. Manufacturer: Siemens Healthineers. Indications: Used for emergency tissue biopsy in acute diabetes situations requiring immediate care.. Contraindications: None\n",
      "Device Name: Dialysis Machine. Model: Max384. Manufacturer: BioMérieux. Indications: Designed for continuous monitoring assistance in geriatric care facilities for elderly patients.. Contraindications: Avoid use if patient has cardiomyopathy or is receiving radioactive materials.\n",
      "            Question: What are the usage of Dialysis Machine Device?\n",
      "            please limit your answer in 50 words.\n",
      "            \n",
      "'Finished running: PromptBuilder:'\n",
      "---CALLING LLM---\n",
      "'Finished running: LLM:'\n",
      "('Usage varies by model: 1703 (Edwards Lifesciences) is for intraoperative '\n",
      " 'measurement monitoring during complex oncological surgeries; Plus593 '\n",
      " '(Siemens Healthineers) is for emergency tissue biopsy in acute diabetes '\n",
      " 'situations requiring immediate care; Max384 (BioMérieux) is designed for '\n",
      " 'continuous monitoring assistance in geriatric care facilities for elderly '\n",
      " 'patients.')\n"
     ]
    }
   ],
   "source": [
    "input_state = {\"query\": \"What are the usage of Dialysis Machine Device?\"}\n",
    "\n",
    "from pprint import pprint\n",
    "for step in agentic_rag.stream(input_state):\n",
    "    for key, value in step.items():\n",
    "        pprint(f\"Finished running: {key}:\")\n",
    "pprint(value[\"response\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 160,
   "id": "ca41ab58",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "---ROUTER DECISION: Web_Search---\n",
      "Web_Search\n",
      "'Finished running: Router:'\n",
      "---PERFORMING WEB SEARCH---\n",
      "Here's a detailed analysis of what a 100% tariff on medicines exported from India to the U.S. might imply — both for the Indian pharma sector ... DGCI&S statistics reveal India's pharmaceutical formulation exports to the US reached $9.8 billion in FY2025, representing 39.8% of its total ... From August 27, 2025, the US tariff on India will increase up to 50 percent, among the steepest measures under the Trump administration. Trump has already slapped 50 per cent tariffs on Indian imports, which also includes a 25 per cent 'penalty' for continued purchase of ... The U.S. ended the $800 de minimis exemption on August 29, 2025. Learn how the new import rules affect prescription medicines, ... U.S President Donald Trump's move to impose 100% tariffs on patented, branded drugs are expected to have a limited impact on India's pharma ... This is estimated to Rs. 85,011 crore in FY 2025. India's 1/3rd of pharma exports revenue was by the United States in 2024 which stood at USD 30 ... A 100% import tax would make Indian drugs substantially less competitive potentially leading to lost market share falling sales and shrinking margins. President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting ... India exported $3.6 billion ( ₹31,626 crore) worth of pharmaceutical products to the US in 2024, and another $3.7 billion ( ₹32,505 crore) in ...\n",
      "'Finished running: Web_Search:'\n",
      "---CONTEXT RELEVANCE CHECKER---\n",
      "---RELEVANCE DECISION: Yes---\n",
      "'Finished running: Relevance_Checker:'\n",
      "---BUILDING PROMPT---\n",
      "\n",
      "            Answer the following question using the context below.\n",
      "            Context:\n",
      "            Here's a detailed analysis of what a 100% tariff on medicines exported from India to the U.S. might imply — both for the Indian pharma sector ... DGCI&S statistics reveal India's pharmaceutical formulation exports to the US reached $9.8 billion in FY2025, representing 39.8% of its total ... From August 27, 2025, the US tariff on India will increase up to 50 percent, among the steepest measures under the Trump administration. Trump has already slapped 50 per cent tariffs on Indian imports, which also includes a 25 per cent 'penalty' for continued purchase of ... The U.S. ended the $800 de minimis exemption on August 29, 2025. Learn how the new import rules affect prescription medicines, ... U.S President Donald Trump's move to impose 100% tariffs on patented, branded drugs are expected to have a limited impact on India's pharma ... This is estimated to Rs. 85,011 crore in FY 2025. India's 1/3rd of pharma exports revenue was by the United States in 2024 which stood at USD 30 ... A 100% import tax would make Indian drugs substantially less competitive potentially leading to lost market share falling sales and shrinking margins. President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting ... India exported $3.6 billion ( ₹31,626 crore) worth of pharmaceutical products to the US in 2024, and another $3.7 billion ( ₹32,505 crore) in ...\n",
      "            Question: What's the export duty on medical tablets on India by USA in 2025?\n",
      "            please limit your answer in 50 words.\n",
      "            \n",
      "'Finished running: PromptBuilder:'\n",
      "---CALLING LLM---\n",
      "'Finished running: LLM:'\n",
      "('100% tariff. The context indicates that in 2025 the U.S. imposed a 100% '\n",
      " 'tariff on Indian medicines, including patented/branded drugs.')\n"
     ]
    }
   ],
   "source": [
    "input_state = {\"query\": \"What's the export duty on medical tablets on India by USA in 2025?\"}\n",
    "\n",
    "from pprint import pprint\n",
    "for step in agentic_rag.stream(input_state):\n",
    "    for key, value in step.items():\n",
    "        pprint(f\"Finished running: {key}:\")\n",
    "pprint(value[\"response\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 163,
   "id": "13003b50",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "---ROUTER DECISION: Retrieve_QnA---\n",
      "Retrieve_QnA\n",
      "'Finished running: Router:'\n",
      "---RETRIEVING CONTEXT---\n",
      "Question: What are the treatments for Acanthamoeba - Granulomatous Amebic Encephalitis (GAE); Keratitis ?. Answer: Early diagnosis is essential for effective treatment of Acanthamoeba keratitis. Several prescription eye medications are available for treatment. However, the infection can be difficult to treat. The best treatment regimen for each patient should be determined by an eye doctor. If you suspect your eye may be infected with Acanthamoeba, see an eye doctor immediately.\n",
      "    \n",
      "Skin infections that are caused by Acanthamoeba but have not spread to the central nervous system can be successfully treated. Because this is a serious infection and the people affected typically have weakened immune systems, early diagnosis offers the best chance at cure.\n",
      "    \n",
      "Most cases of brain and spinal cord infection with Acanthamoeba (Granulomatous Amebic Encephalitis) are fatal.. Type: treatment. \n",
      "Question: What are the treatments for Sarcoidosis ?. Answer: What treatment is available for sarcoidosis? The treatment of sarcoidosis depends on :  the symptoms present the severity of the symptoms whether any vital organs (e.g., your lungs, eyes, heart, or brain) are affected how the organ is affected. Some organs must be treated, regardless of your symptoms. Others may not need to be treated. Usually, if a patient doesn't have symptoms, he or she doesn't need treatment, and probably will recover in time. Currently, the drug that is most commonly used to treat sarcoidosis is prednisone.  When a patient's condition gets worse when taking prednisone or when the side effects of prednisone are severe in the patient, a doctor may prescribe other drugs. Most of these other drugs reduce inflammation by suppressing the immune system. These other drugs include: hydroxychloroquine (Plaquenil), methotrexate, azathioprine (Imuran), and cyclophosphamide (Cytoxan). Researchers continue to look for new and better treatments for sarcoidosis. Anti-tumor necrosis factor drugs and antibiotics are currently being studied. More detailed information about the treatment of sarcoidosis can be found at the following links: https://www.stopsarcoidosis.org/awareness/treatment-options/ http://emedicine.medscape.com/article/301914-treatment#showall. Type: treatment. \n",
      "Question: What are the treatments for CADASIL ?. Answer: There is no treatment to halt this genetic disorder. Individuals are given supportive care. Migraine headaches may be treated by different drugs and a daily aspirin may reduce stroke and heart attack risk. Drug therapy for depression may be given. Affected individuals who smoke should quit as it can increase the risk of stroke in CADASIL. Other stroke risk factors such as hypertension, hyperlipidemia, diabetes, blood clotting disorders and obstructive sleep apnea also should be aggressively treated... Type: treatment. \n",
      "'Finished running: Retrieve_QnA:'\n",
      "---CONTEXT RELEVANCE CHECKER---\n",
      "---RELEVANCE DECISION: No---\n",
      "'Finished running: Relevance_Checker:'\n",
      "---PERFORMING WEB SEARCH---\n",
      "FDA has authorized or approved several antiviral medications used to treat mild to moderate COVID-19 in people who are more likely to get very sick. These medicines keep mild illness from getting worse. They can include nirmatrelvir-ritonavir (Paxlovid), remdesivir (Veklury) or molnupiravir ... The treatments available for people at the highest risk of becoming seriously ill from COVID-19 are: Nirmatrelvir plus ritonavir, and molnupiravir are ... Take an over-the-counter medicine such as acetaminophen or ibuprofen. These can be used as a fever reducer or to treat headache, sore throat or body aches. Oral antiviral drugs authorized for treatment of COVID-19 · Paxlovid · Lagevrio (also called molnupiravir). These medications stop the virus ... by SS Jean · 2020 · Cited by 94 — Remdesivir, teicoplanin, hydroxychloroquine (not in combination with azithromycin), and ivermectin might be effective antiviral drugs and are deemed promising ... Oral antivirals are a pill taken by mouth for the treatment of COVID-19 in certain people. They are available by prescription only. The oral ... PAXLOVID is a prescription medicine used to treat mild-to-moderate coronavirus disease 2019 (COVID‑19) in adults who are at high risk for progression to severe ... For certain hospitalized adults with COVID-19, the FDA has also approved Olumiant (baricitinib) and Actemra (tocilizumab). Under certain ... PaxlovidQuizMolnupiravirRemdesivirHospital medicationsPreventative medicationsCurrently unavailablePipeline medications ...\n",
      "'Finished running: Web_Search:'\n",
      "---CONTEXT RELEVANCE CHECKER---\n",
      "---RELEVANCE DECISION: Yes---\n",
      "'Finished running: Relevance_Checker:'\n",
      "---BUILDING PROMPT---\n",
      "\n",
      "            Answer the following question using the context below.\n",
      "            Context:\n",
      "            FDA has authorized or approved several antiviral medications used to treat mild to moderate COVID-19 in people who are more likely to get very sick. These medicines keep mild illness from getting worse. They can include nirmatrelvir-ritonavir (Paxlovid), remdesivir (Veklury) or molnupiravir ... The treatments available for people at the highest risk of becoming seriously ill from COVID-19 are: Nirmatrelvir plus ritonavir, and molnupiravir are ... Take an over-the-counter medicine such as acetaminophen or ibuprofen. These can be used as a fever reducer or to treat headache, sore throat or body aches. Oral antiviral drugs authorized for treatment of COVID-19 · Paxlovid · Lagevrio (also called molnupiravir). These medications stop the virus ... by SS Jean · 2020 · Cited by 94 — Remdesivir, teicoplanin, hydroxychloroquine (not in combination with azithromycin), and ivermectin might be effective antiviral drugs and are deemed promising ... Oral antivirals are a pill taken by mouth for the treatment of COVID-19 in certain people. They are available by prescription only. The oral ... PAXLOVID is a prescription medicine used to treat mild-to-moderate coronavirus disease 2019 (COVID‑19) in adults who are at high risk for progression to severe ... For certain hospitalized adults with COVID-19, the FDA has also approved Olumiant (baricitinib) and Actemra (tocilizumab). Under certain ... PaxlovidQuizMolnupiravirRemdesivirHospital medicationsPreventative medicationsCurrently unavailablePipeline medications ...\n",
      "            Question: What are medicines/treatment for COVID?\n",
      "            please limit your answer in 50 words.\n",
      "            \n",
      "'Finished running: PromptBuilder:'\n",
      "---CALLING LLM---\n",
      "'Finished running: LLM:'\n",
      "('Medicines include oral antivirals Paxlovid (nirmatrelvir–ritonavir) and '\n",
      " 'Lagevrio (molnupiravir); the IV antiviral remdesivir; and, for some '\n",
      " 'hospitalized patients, baricitinib (Olumiant) and tocilizumab (Actemra). '\n",
      " 'Over-the-counter fever/pain relief like acetaminophen or ibuprofen can help '\n",
      " 'with symptoms.')\n"
     ]
    }
   ],
   "source": [
    "input_state = {\"query\": \"What are medicines/treatment for COVID?\"}\n",
    "\n",
    "from pprint import pprint\n",
    "for step in agentic_rag.stream(input_state):\n",
    "    for key, value in step.items():\n",
    "        pprint(f\"Finished running: {key}:\")\n",
    "pprint(value[\"response\"])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv (3.12.9)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
